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ABSTRACT
To become activated and perform effector functions, naive T cells move within lymph
nodes to scan dendritic cells presenting antigen. Previous work has shown naive T cell
activation is promoted by interleukin 7 in vivo, and it does so by regulating the T
cell:dendritic cell interaction. Our work identifies a novel role for IL-7 in mediating naive
T cell motility in the lymph node and promoting T cell association with DCs. Additionally,
we have developed a method for analyzing microscopy images, regionalized normalized
mutual information, to assess intercellular associations between T cells and other cells
within the lymph node. Dendritic cells and stromal cells are thought to be positioned
optimally within the T cell zone of the lymph node to increase the probability of T cells
interacting with dendritic cells. We find that T cells are less associated with dendritic cells
and more associated with stromal cells in the lymph node. Our data demonstrate a new
function of IL-7 in naive T cells and quantify the relationship between naive T cell
positioning relative to localization of stromal cells, dendritic cells, and blood vessels.
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CHAPTER 1: Introduction
1.1. Adaptive immune response
1.1.1. Overview
Organisms have evolved by means of surviving infection by pathogens, and in
doing so have generated a system of cell types that protects against foreign (i.e. molecule
not generated by the host) matter. The immune system consists of physical barriers,
defensive and offensive molecules, and specific and non-specific cellular responses to
safeguard the host. Vertebrate immune systems can respond to insults with hematopoietic
cells that have protective function genetically encoded (i.e. innate immune cells) and
hematopoietic cells that require education by the host and functional activation to effect a
response (i.e. adaptive immune cells). When a pathogen or foreign substance enters the
body by breaching a barrier (e.g. via a wound or an invasive microorganism), it is first
recognized by cells of the innate immune system, which then coordinate a response to result
in activation of the adaptive immune system leading to eventual clearance of the pathogen.
1.1.2. Cell types that mediate adaptive immune responses
Lymphocytes are adaptive immune cells that are distinct from innate cells in that
they can (a) recognize a pathogen-specific molecular patterns, or antigen, and provide longterm protection (i.e. immunity) against a specific pathogen. For example, there is generally
lasting immunity to rubella once an adaptive immune response has cleared a rubella
infection, and this is due to maintenance of lymphocyte populations that were specifically
activated by rubella. The great diversity of the lymphocyte population, which enables
responses to an extraordinary number of pathogens, is acquired throughout life as exposure
to individual pathogens occurs. B cells and T cells are the main categories of lymphocytes,
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and there are numerous phenotypes of effector B and T cells with more being classified
each year.
B cells have surface receptors that are generated by recombining genetic elements
so that the resulting B cell pool has a diverse number of B cell receptors (BCR) that can
recognize a massive pool of antigen. B cells produce antibody in response to antigen
recognition, and T cells can provide signaling to promote antibody production. B cells can
also present antigen to T cells. Though B cells and T cells can interact with each other for
specific immune functions, T cells have distinct functions and the following work focuses
on T cell biology.
T cells also have surface receptors that recognize specific pathogens, but they are
distinct from B cells in their development and the type of antigen recognized. Most T cells
have TCRs that recognize linear peptides of antigen that have been processed by antigen
presenting cells (APCs) and are presented on major histocompatibility complex (MHC),
although there are types of T cells with TCRs that recognize non-peptide antigen, such as
lipid particles (De Libero and Mori, 2005). Stimulation of the TCR by the antigen and
costimulation by other surface molecules induces activation of the T cell and activated T
cells can perform effector functions such as eliminating virally-infected cells or producing
cytokines.
1.1.3. T cell Development and Maturation
T cells, like B cells, are derived from hematopoietic stem cells that differentiated
into common lymphoid progenitors. Common lymphoid progenitors migrate out of the
bone marrow and into the thymus where they develop through thymocyte stages into
mature T cells. Stages of development are defined by differential gene expression of CD44
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and the interleukin 2 (IL-2) receptor, CD25, and by specific developmental checkpoints
that eliminate both non-responsive and autoreactive thymocytes.
The earliest stage of T cell development after the thymocyte has been specified to
the T cell lineage is double negative (DN) 2, which are CD44+CD25+, but are termed DN
due to the lack of coreceptor molecules CD4 and CD8. DN2 cells rearrange genes from the
TCR β chain locus and the cell is termed DN3 when a functional TCR β chain is formed
(Godfrey et al., 1993; Kishi et al., 1991). The DN3 thymocyte downregulates CD44
expression and forms a pre-TCR by generating an invariant α chain and associating the
signaling molecule CD3 zeta chain to the invariant α chain and β chain (von Boehmer,
2005; Snodgrass et al., 1985). This process is called beta selection, and if the rearranged β
chain successfully pairs with an invariant α chain, survival is conferred. CD25 expression
is downregulated and CD4 and CD8 are upregulated, resulting in double positive (DP)
thymocytes. The pre-TCR α chain undergoes gene rearrangements to produce a true αβ
TCR. The DP thymocyte is then subject to positive selection in which the TCR engages
with self antigen presented on MHC (pMHC) by thymic epithelial cells (Klein et al., 2014).
Much of the interaction between a T cell and an APC is through the TCR:MHC interaction,
so DP thymocytes with some affinity for the self pMHC will survive, while insufficient
binders will apoptose. Later, negative selection eliminates DP thymocytes that interact too
strongly with self pMHC presented on APCs (Klein et al., 2014). This selects for DP
thymocytes that are not autoreactive and results in downregulation of one of the
costimulatory molecules, CD4 or CD8 (Teh et al., 1988). Resulting thymocytes are
considered single positive (SP) mature T cells which migrate out of the thymus into the
circulation (Weinreich and Hogquist, 2008). Most mature T cells express either CD4 or
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CD8, which are TCR coreceptors for the TCR at the immunological synapse (the location
where the T cell interacts with antigen on MHC). There exists a small population of T cells,
gamma delta T cells, that do not express either of these markers, and they generate a
different TCR comprised of gamma and delta chains instead of alpha and beta chains
(Xiong and Raulet, 2007).
1.1.4. Requirement for IL-7 in development
Interleukin 7 (IL-7) is an obligate cytokine for T cells during development. IL-7R
expression and signaling is essential for progression of T cells past the DN3 stage (von
Freeden-Jeffry et al., 1995; Grabstein et al., 1993; Peschon et al., 1994; Sudo et al., 1993),
and IL-7R signaling induces Rag1 and Rag2 activity for gene rearrangements at both the
TCRβ and TCRɣ loci to make functional pre-TCRs (Durum et al., 1998; Maki et al., 1996;
Muegge et al., 1993). During positive selection (after productive association of a β chain
and an α chain), the IL-7R is not expressed at the surface. DP thymocytes are neglected
and will die if not positively selected by TCR stimulation. Positive selection (affinity for
pMHC on thymic epithelial cells) results in upregulation of IL-7R, migration of the
thymocyte to the cortico-medullary junction (out of the cortex toward the medulla) and
subsequent survival signaling. Survival signaling occurs through the IL-7Rα chain and the
common ɣc to receptor-associated Jak1 and Jak2. These kinases then upregulate Bcl-2 (an
anti-apoptotic molecule) via STAT5 activation. IL-7R upregulation after this checkpoint
also determines differentiation of the T cell, as IL-7R signaling downregulates CD8
expression, leaving the thymocyte CD4+. Research by Park et al. verified this by enforcing
expression of IL-7R on DP thymocytes that could not undergo positive selection (non-
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functional TCR) and treating the cell with IL-7. Forced IL-7R signaling resulted in a
skewing of the thymocyte fates to CD8+ SP cells (Park et al., 2010b).
1.1.5. T cell survival in the periphery and lymph node
After maturation, SP CD4 and CD8 naïve T cells migrate out of the thymus and
into the circulation. Naïve T cells migrate across the small blood vessels termed high
endothelial venules (HEV) into the paracortex, or T cell zone, of the lymph node (LN).
This occurs by transendothelial migration and is regulated by chemokines, integrins, and
adhesion molecules. Endothelial cells lining HEVs express glycosylated mucins (e.g.
PNAd, and CD34, GlyCAM-1) that bind CD62L on T cells, and this interaction mediates
tethering of a naïve T cell to the HEV wall in the presence of shear force from blood flow.
CD62L interaction with PNAd-expressing HEV endothelial cells does not cause strong
adhesion, but rolling of the T cell along the HEV wall as the adhesion molecules bind and
unbind to the mucins. Chemokines such as CCL19 and CCL21 are produced by blood
endothelial cells and promote migration of T cells out of the blood and into the LN by
signaling through CCR7 on T cells. Naïve T cells from CCR7-/- mice that have been
adoptively transferred into wildtype mice exhibit a lymph node homing defect (Förster et
al., 1999). In addition to CCR7, Lysophosphatidyl choline is abundant in blood and is
catalyzed by endothelial cell-secreted autotaxin to lysophosphatidic acid (LPA). Autotaxin
is hypothesized to bind to T cells in the HEV and produce a high local concentration of
LPA, which then binds to LPA receptors (LPARs) which also facilitates T cell homing to
the LN (Kanda et al., 2008; Zhang et al., 2012). Autotaxin can bind to T cells in vitro and
intravenous injection of a catalytically dead form of autotaxin has been shown to
competitively inhibit LN homing of murine T cells (Kanda et al., 2008).
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Binding of CCL21/CCL19 and LPA to their receptors on T cells (CCR7 and
LPARs), activate integrins on T cells via inside-out signaling, in which signaling from
within the T cells mediates a conformational change of a transmembrane molecule to
activate the high affinity conformation of the integrin LFA-1 (Abram and Lowell, 2009;
Kliche et al., 2012). Integrins LFA-1 and VLA-4 on T cells bind to ICAM-1 and VCAM1 on endothelial cells (Greenwood et al., 1995), respectively, and can also bind to
extracellular matrix proteins such as collagen and fibronectin. These interactions mediate
firm adhesion and stopping of the naïve T cell on HEVs, and the T cells can then
extravasate to the lymph node paracortex. To migrate between endothelial cells in the HEV,
matrix metalloproteinases have been shown to digest extracellular matrix and are
associated with normal T cell diapedesis. Inhibition of MMPs has been shown to result in
more naïve T cells localized in the lining near the perivascular basement and lumen of the
HEVs, and fewer naïve T cells in the interstitial space (Faveeuw, 2001). In addition to the
lymph nodes, naïve T cells also home to the spleen, another secondary lymphoid organ.
Entry to the white pulp of spleen occurs by a similar process with chemokine-mediated
migration, though spleens don’t have HEVs (Bajénoff et al., 2008).
1.1.5.1. IL-7 in T cell survival in periphery
While in the LN paracortex, T cells are maintained by survival signals. An obligate
survival signal for T cells in vivo is IL-7. IL-7 promotes survival by upregulating antiapoptotic factor Bcl-2, as transgenic expression of Bcl-2 in vivo can fully rescue the T cell
population in the absence of IL-7R signaling (Akashi et al., 1997; Maraskovsky et al.,
1997). Due to the requirement for IL-7 during T cell development in the thymus, it has
been challenging to determine the effect of IL-7 on mature T cell survival in the periphery.
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Vivien et al. thymectomized adult mice to ensure normal mature T cells and prevent
additional thymic output, then administered anti-IL-7R antibody which blocks IL-7 from
binding IL-7R on the T cell. Phenotyping T cell populations after anti-IL-7R treatment
revealed the T cell population diminished by half over 2-3 weeks, and that naïve CD4+ T
cells were more susceptible to death from IL-7 neglect (Vivien et al., 2001). In mature T
cells, IL-7 inhibits Bim (pro-apoptotic) (Li et al., 2010), upregulates Bcl-2, Mcl-1 (antiapoptotic) (Opferman et al., 2003), and prevents translocation of pro-apoptotic Bad and
Bax from the cytoplasm to the mitochondria (Khaled et al., 1999; Li et al., 2004). Outside
of the LN, circulating T cells are presumed to have less access to IL-7 for survival. IL-7
can only be detected in IL-7 reporter mice in the thymus, intestines, and skin. Interestingly,
intestinal IL-7 production seems to be dependent on IFNɣ production induced by the
microbiome (Shalapour et al., 2010).
1.1.6. Homeostatic and antigen-induced proliferation
T cells home to LNs for survival signaling and to patrol APCs for cognate antigen.
APCs in the T cell zone are largely dendritic cells (DCs). DCs uptake antigen in the
periphery and migrate to the paracortex in a CCR7-dependent manner. DCs in the LN can
also uptake antigen that has drained into the LN via lymphatic fluid. T cells move rapidly
(7-20 µm min-1) within the paracortex and contact relatively sessile DCs that are presenting
antigen on MHC (pMHC). When a T cell encounters the antigen cognate to its TCR and
makes a productive interaction, the T cell signals through the TCR and activates.
The immunologic synapse forms in the following order to facilitate T:DC
interactions: LFA-1 (an adhesion protein on the T cells) and ICAM-1 (on the DC) interact
to stabilize the moving T cell and allow for membrane scanning of the DC (Comrie et al.,
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2015a, 2015b; Grakoui et al., 1999); LFA-1 (on the DC) and ICAM-1 (on the T cell)
modulates the duration of the T:DC interaction (Balkow et al., 2010); TCR and pMHC
interaction leads to inside-out signaling of LFA-1, resulting in strong adhesion and a stop
in T cell motility (Feigelson et al., 2011; Walling and Kim, 2018).

CD28 (T cell

costimulatory molecule) and CD80 (CD28 ligand on the surface of APCs) engage to
promote signaling through the TCR (Beyersdorf et al., 2015; Chen, 2004). Microclusters
of many TCRs, coreceptors, and integrins form at the T:DC interface to stabilize the
intercellular interaction and allow even weak affinity antigen to transduce a signal through
the TCR (Hashimoto-Tane and Saito, 2016; Krummel et al., 2000). Microcluster formation
also induces recruitment of kinases required for TCR signaling and allows for prolonged
signaling through the complex for signal integration leading to T cell activation (Bunnell
et al., 2002; Yokosuka et al., 2005). In addition to the conditions required for T:DC
interactions, the following variables have been reported to have an effect on the
proliferation outcome: affinity of the pMHC to the TCR; dwell time of ligand-receptor
interactions and number of contacts at the immunologic synapse; the abundance of ligand;
the amount of pro-proliferative cytokines such as IL-7; and the number of T cells in the
LN. Here we will focus on the contribution of IL-7 to homeo-static and antigen-induced
proliferation.
1.1.6.1. Homeostatic proliferation and a role for IL-7
The count and composition of the naïve T cell pool is maintained via proliferation.
The regulation of homeostatic proliferation is critical in preserving diversity and preventing
expansion of specific naïve clones. Additionally, it would be disadvantageous to have a
disproportionate number of naïve T cells relative to effector and memory T cells, or
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skewing in the balance of CD4 and CD8 T cells. In normal conditions, naïve T cells divide
at a slow rate. This ensures that the diversity of the TCR repertoire is maintained, but total
T cell numbers do not vary. The most well understood role for IL-7 in lymphocyte
proliferation comes from its function in homeostatic proliferation upon lymphopenia.
Lymphopenia induces a burst in proliferation and diversity in the T cell population. The
current model for homeostatic proliferation is one in which T cells in the lymph node are
competing for growth factors and survival factors which are at growth-limiting levels for
the population. As T cells turnover there is a slow, steady cycling of T cells that can access
the mitogens and survival signals. There is debate regarding the mechanism that induces
mass proliferation. One hypothesis is that when there are fewer T cells, competition for
growth factors is less and a larger proportion of the T cells can access the mitogens (Min
et al., 2005), Another hypothesis is that the survival signals become mitogenic during
lymphopenia when the same signal would have only provided pro-survival signaling in
lymphoreplete conditions.
IL-7 is critical for proliferation following lymphopenia. Fewer naïve T cells during
lymphopenia corresponds with less IL-7 signaling and internalization, which increases the
concentration of IL-7 in the paracortex. At homeostasis, there is competition among T cells
for IL-7, but the higher concentration of IL-7 in lymphopenic animals is an abundance and
mitogenic when combined with self peptide:MHC interactions. Tan et al. demonstrated
that IL-7 is required for in vivo homeostatic proliferation using a model of lymphopenia in
which mice are irradiated to abrograte their hematopoietic popoulations. Cell divisions of
naïve CD8+ T cells in lymphopenic IL-7- mice were reduced when compared to
lymphopenic WT mice. Administering IL-7 to the lymphopenic IL-7- returned the
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proliferative ability of the CD8+ population to normal levels. Interestingly, this was found
to be independent of Bcl-2 upregulation by IL-7 (Tan et al., 2001), which establishes a role
for IL-7 in proliferation beyond its role as a trophic factor. Schluns et al. also identified IL7 as an important regulator of in vivo homeostatic proliferation of CD4+ and CD8+ T cells
in lymphopenic mice by demonstrating impaired proliferation in naïve T cells transferred
to Rag1-/-IL-7-/- mice compared to naïve T cells transferred to Rag1 -/- mice (Schluns et al.,
2000).
1.1.6.2. Antigen-induced proliferation and a role for IL-7
Various cytokines have been used to augment T cell proliferation in vitro, but there
has been opposing data as to which cytokines are essential for or amplify antigen-induced
proliferation in vivo. In vitro, IL-7 has been shown to increase T cell expansion (Armitage
et al., 1990; Kos and Müllbacher, 1992, 1993; Londei et al., 1990; Morrissey et al., 1989;
Steffens et al., 2002; Vieira et al., 1998; Webb et al., 1999; Welch et al., 1989), though
several groups report that IL-7 has no effect on in vitro stimulation of naïve T cells
(Costello et al., 1993; Dardalhon et al., 2001; Geginat et al., 2001; Grabstein et al., 1990;
Hassan and Reen, 2001). In vivo, IL-7 is critical for clonal proliferation in response to
antigen. Saini et al. generated inducible IL-7R-deficient mice with a transgenic T cell
population specific for an influenza peptide and transferred the IL-7R- or IL-7R+ T cells
into Rag1-/- mice and subsequently infected the mice with influenza. The IL-7R- T cell
population exhibited reduced proliferation relative to the IL-7R+ T cell population (Saini
et al., 2009). In the same study, the authors found no defect with in vitro T cell expansion
in response to TCR stimulation in the absence of IL-7R signaling, leading to the hypothesis
that IL-7 influences T:DC contacts instead of directly affecting signaling downstream of
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TCR. This finding, in addition to other studies in which IL-7 was not found to costimulate
antigen-induced proliferation, suggests IL-7 may promote T cell search for antigen in vivo,
whereas this is not a factor in vitro where stimuli are available in saturation.
1.1.6.3. IL-7R potential as a motility inducer
1.1.6.3.1. IL-7 may affect T cell motility as a metabolic regulator
Non-chemotactic cytokines and growth factors have the potential to stimulate cell
migration as trophic factors that promote metabolism or as modulators of chemokine
receptor expression. IL-7 is critical for T cell development, survival, and in vivo activation,
but its activity as a regulator of T cell search is unstudied. IL-7 is a trophic factor for naïve
T cells, and the resulting growth from IL-7R signaling is due to activation of metabolism.
This metabolic activity is hypothesized to translate into an increased efficiency of scanning
of DCs in the LN (Saini et al., 2009). Known metabolic effects of IL-7 include increasing
glucose metabolism and cellular respiration (Jacobs et al., 2010a; Rathmell et al., 2001;
Wofford et al., 2008). Rathmell et al. compared glycolysis rates of T cells isolated from
murine LNs and spleen that had either been fresh from the mouse tissue, isolated and
neglected (i.e. without IL-7 supplementation) for 24 hours, or isolated and cultured in the
presence of 0.1 ng mL-1 IL-7 for 24 hours. IL-7 supplementation maintained glycolysis
rates via mTOR activation, but this effect was independent of Bcl-2 upregulation (Rathmell
et al., 2001). These data show that IL-7 affects T cell metabolism in addition to survival.
The mechanism underlying IL-7 regulation of glucose metabolism was further delineated
by Wofford et al. Surface expression of Glut1, a glucose transporter, was identified to be
critical for glucose uptake, and trafficking of Glut1 was dependent on IL-7R signaling. IL7R signaling to Glut1 trafficking was found to be through activation of STAT5 to
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transcriptional events resulting in phosphorylation of Akt (Wofford et al., 2008). In
humans, recombinant IL-7 therapy in septic shock patients augments T cell proliferation,
glucose uptake, and GLUT1 trafficking, and this was dependent on mTOR activation
(Venet et al., 2017).
While glucose uptake is critical for motility of various cell types, including effector
T cells (Haas et al., 2015) and Treg cells (Kishore et al., 2017), the effect of glucose
metabolism and mTOR activation on naïve T cell motility and search for antigen is
unknown. In fact, the mechanism of glucose regulation of motility is different for effector
T cells and Treg cells, so there may be a distinct mechanism for naïve T cell motility
mediated by glycolysis and/or mTOR, too. This would be consistent with the metabolic
shift that occurs from oxidative phosphorylation to aerobic glycolysis when a naïve T cell
becomes activated, as well as the differential requirements for IL-7 by naïve, effector, and
memory T cells.
1.1.6.3.2. IL-7 may affect T cell motility as a regulator of chemokine receptor expression
Another possible mechanism by which IL-7 may promote naïve T cell motility in
the LN is through chemokine receptor modulation. Thymic epithelial cell-derived IL-7 has
been shown to upregulate and promote signaling through CXCR4 on mature SP
thymocytes (Schmitt et al., 2003). Additionally, IL-7 upregulates CXCR4 expression and
enhances migration toward CXCL12 on in vitro-generated memory T cells (Jourdan et al.,
2000). Multiple chemokine receptors have also been shown to be overexpressed in
macaques after injection of glycosylated recombinant simian IL-7. IL-7 treatment also
increased production of CCL19 and CCL21 (CCR7 ligands) in LNs and gut, which resulted
in significant homing of T cells to these organs (Beq et al., 2009). Despite clear evidence
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for a role in IL-7 in regulating chemokine receptor expression and circulating T cell
migration, IL-7 has not been investigated as a regulator of T cell motility in the LN.
1.1.7. Naïve T cell motility in the lymph node
In T cell search in the LN, T cells scan DCs for their cognate antigen or for normal
maintenance of the naïve population, but productive interactions between T cells and DCs
are rare considering how few T cells recognize a given pMHC complex and the peptide
dose within the LN. Naïve T cells move rapidly (10-20 µm min-1) and spend 4-12 hours in
a LN before reentering the circulation. The time from when antigen is presented on MHC
in the LN to when a T cell contact is made with the DC underlies the timing of the T cell
response. Because T cell motility in the LN is a determinant of T cell response efficiency,
many studies have focused on molecules that induce motility and cells or structures in the
paracortex that may affect how T cells search for cognate antigen within the lymph node.
1.1.7.1. Molecules that stimulate motility in the paracortex
1.1.7.1.1. GPCR signaling
In naïve T cells, chemokines and bioactive lipids can signal through heterotrimeric
G protein-coupled receptors (GPCRs) to generate cell motion. GPCR signaling causes
cytoskeleton reorganization through multiple pathways in various cell types, including
epithelial cells, myeloid immune cells, and lymphocytes (Vázquez-Victorio et al., 2016).
Binding of a ligand to a GPCR signals through GTP-bound Gα protein to disassociate from
its βɣ subunits and activate G protein receptor kinases which phosphorylate downstream
effectors (Cotton and Claing, 2009). The βɣ subunits can also have motility-inducing
activity which varies based on the G protein. Blockade of GPCRs in T cells in vivo leads
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to loss of cell growth (atrophy), reduced cell motility and migration, and stunted
proliferation (Cinalli et al., 2005).
Naïve T cell chemokines generally signal through Gαi-associated GPCRs and can
be inhibited by Pertussis toxin (Ptx), which dislodges the Gα subunit from the GPCR by
ADP-ribosylating a cysteine in the Gα binding site (Kaslow and Burns, 1992; Spangrude
et al., 1985). Ptx-treated T cells exhibit speed reductions of 60% in the naïve LN (AspertiBoursin et al., 2007). While this is dramatic, there is residual T cell speed indicating
additional factors can drive naïve T cell motion. Specific GPCR ligand activity has been
interrogated through cell knockouts and inhibitors. CCL21 is produced by fibroblastic
reticular cells (FRCs) in the paracortex and binds CCR7 on T cells (Luther et al., 2000).
CCR7-/- T cells exhibit reduced speed compared to wildtype T cells, moving within the LN
at ~5 µm min-1 (Asperti-Boursin et al., 2007; Worbs et al., 2007). Autotaxin is also
expressed on the surface of FRCs (as well as T cells), and it has been shown that
pharmacologic inhibition of autotaxin as well as conditional knockout of autotaxin in FRCs
results in ~20% reduction in naïve T cell speed (Katakai et al., 2014; Knowlden et al., 2014;
Takeda et al., 2016; Tanikawa et al., 2010; Zhang et al., 2012). Takeda et al. demonstrated
that LPA2, one isoform of LPAR, mediates the ATX-LPA motility effect in naïve T cells
(Takeda et al., 2016). While it is clear that CCR7 and LPAR signaling promote motility in
the paracortex, the residual motility after blocking Gαi-associated GPCRs indicates the
existence of other motility-inducing signals.
1.1.7.1.2. Cell types and structures that may facilitate T cell movement
The LN paracortex is most abundant in stromal cells, DCs, T cells, and HEVs.
These cell types produce molecules that enhance T cell migration and motility as well as
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provide a physical substrate with which T cells can interact. Knowledge of how these cells
and LN structures influence the T cell search for antigen would be valuable for
understanding T cell activation efficiency in infection.
Stromal cells in the paracortex include fibroblastic reticular cells (FRCs), which
encapsulate lymphatic vessels and form a network within the LN. Bajenoff et al. used
microscopy of mouse LNs to visualize T cells in contact with the FRC network,
hypothesizing that naïve T cells move along the FRC network (Bajénoff et al., 2006),
similar to how cars only drive on roads. FRCs produce CCR7 ligands which attract and
keep T cells in the paracortex (Luther et al., 2000), and these molecules are also important
for DC motility (Sallusto and Lanzavecchia, 2000) and antigen uptake (Yanagawa and
Onoé, 2003). These results suggest a model whereby T cells move along the FRC network
in a CCR7-dependent manner to associated DCs that are also attracted to the FRC network
by CCR7 ligands, but direct experimental confirmation of FRC guidance of T cell motion
is still lacking. Katakai et al. showed DCs appear near FRCs (Katakai et al., 2013), and that
DCs can probe into the FRC lymphatic lumen to uptake antigen (Sixt et al., 2005a). Sixt et
al. also observed DCs within the FRC network, but noted that most DCs were not in contact
with the FRC network (Sixt et al., 2005a). However, direct recruitment of T cells to the
FRC network in vivo has not been demonstrated.
The bulk of IL-7 in the LN is made by FRCs to maintain T cell homeostasis
(Mueller and Germain, 2009). FRC involvement in functional immunity is undisputed, as
FRC-deficient mice are susceptible to viral infections and mount subpar antibody responses
(Chai et al., 2013; Matsushita et al., 2013). FRC network competency (i.e. the ability to
produce chemokines and homeostatic cytokines such as IL-7) is dependent on lympotoxin
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β, which is produced by lymphoid tissue inducer cells during embryonic development and
T cells later in life (Chai et al., 2013). Additionally, computational modeling identified that
T cell-derived lymphotoxin β is essential for FRC production of IL-7, and reduction of IL7 led to apoptosis of T cells (Donovan and Lythe, 2016). There seems to be a mutual
dependence between FRCs and T cells (Koning and Mebius, 2012), but whether IL-7
increases association of T cells with FRCs to promote T cell interaction with DCs is
unclear.
Aside from secretion of cytokines and chemokines, the FRC network is thought to
provide a medium for friction-based motion of T cells. FRCs express adhesion molecules
VCAM-1 and ICAM-1 (Bajénoff et al., 2006; Katakai et al., 2004). Naïve T cells express
integrins VLA-4 and LFA-1, which bind to VCAM-1 and ICAM-1, respectively. While it
is known T cells adhere to surfaces by LFA-1:ICAM-1 interactions during transendothelial
migration and in vitro (Park et al., 2010a), there is uncertainty regarding the role for LFA1:ICAM-1 interactions in the LN paracortex. Chemokine-mediated motility in the absence
of shear force (as in the paracortex) does not stimulate integrin activation, and T cells can
move without strong adhesion from LFA-1:ICAM-1 interactions (Woolf et al., 2007).
Despite this, some LFA-1-ICAM-1-mediated motility occurs in the LN. Katakai et al.
resolved that DCs are the main source of LFA-1-dependent motility of T cells by
generating bone marrow chimeric mice in which ICAM-1-/- mice were irradiated and
reconstituted with WT bone marrow, or WT mice were irradiated and reconstituted with
ICAM-1-/- bone marrow. T cell velocities were slowest in the WT mice with ICAM-1deficient hematopoietic cells, indicating FRCs play a dispensable part in LFA-1:ICAM-1mediated motility (Katakai et al., 2013). If T cells do use the FRC network as motility-
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promoting infrastructure, the molecular interactions likely to not use integrin-mediated
mechanisms, and may rely on amoeboid walking (Jacobelli et al., 2009).
FRC-mediated migration of DCs has also been studied. Hayakawa et al also showed
ultra structurally that interdigitating cells (likely DCs) are in contact with the FRC network,
occupying ~10% of the surface area of the FRC (Hayakawa et al., 1988). The FRC network
provides structure and demarcates the LN paracortex, and Astarita and colleagues
determined that the structural tension is due to podoplanin intracellular signaling to stiffen
the FRC cytoskeleton. When CLEC-2 (a C-type lectin receptor) on DCs binds and blocks
podoplanin on FRCs, the cytoskeleton relaxes (Acton et al., 2014). In the context of
antigen, there is an influx of DCs to the paracortex, and consequently more CLEC2:podoplanin binding. Imaging shows that this changes the number of T cells in contact
with the FRC network and the capacity of the LN for cellular expansion (Astarita et al.,
2015). The CLEC-2:podoplanin interaction also stimulates motility of DCs along the FRC
network by a tetraspanin CD37 (Acton et al., 2012a) (Winde et al., 2018). Modeling
different densities of the FRC network in a simulation of the naïve LN suggests that the
FRC network likely does not increase contacts between T cells and DCs (Graw and Regoes,
2012), but this has not been confirmed experimentally. While T cells have been shown to
be in contact with the FRC network and DC motility along FRCs has been shown to occur,
questions remain regarding the precise amount of association between T cells and FRCs,
and whether this affects the rate of DC scanning by T cells.
Embedded in the LN paracortex are HEVs, and T cells enter the LN via
transendothelial migration from the HEV lumen to the LN interstitium. Before undergoing
diapedesis, T cells crawl along the inside of the HEV in a process dictated by chemokines,

18

integrins, and adhesion molecules (Andrew et al., 1998; von Andrian and Mempel, 2003;
Stein et al., 2000; Warnock et al., 1998). Chemokines are presented on the luminal surface
of the HEV. Some chemokines are produced by the HEV endothelial cells (e.g. CCL21),
but others, such as CCL19, have been shown to be transported from the lymphatic conduits
of the FRC network where the chemokine is produced (Baekkevold et al., 2001). The FRC
conduits are contiguous with HEVs, sparking another hypothesis that T cells can move
from the HEV to the FRC network to begin scanning DCs in an organized manner.
Labelled, transferred T cells have been observed exiting the HEV onto FRC fibers by
Bajenoff et al (Bajénoff et al., 2006), though it is uncertain whether T cell always enter the
paracortex via this method or if T cells remain in prolonged contact with FRCs for T cell
motility. HEVs may also contribute to motility in the paracortex after T cells have migrated
into the interstitium. T cells have been shown to abluminally crawl along vasculature in
other tissues, such as brain and lung (Bartholomäus et al., 2009; Mrass et al., 2017), and it
is possible T cells use both the FRC network and HEVs indiscriminately for motion.
DCs in the paracortex of the naïve LN are generally nonmoving but actively
protrude dendrites in a probing behavior (Lindquist et al., 2004). DCs present antigen to
naïve T cells, and and thus are the ultimate targets of naïve T cells. The current paradigm
in immunology is that T cells continually scan the surface of DCs while in the LN in search
of cognate antigen, but whether DCs directly attract T cells is unknown. Miller et al.
generated mouse model in which pan-DC populations are fluorescent, the authors observed
that T cells appear to move randomly and do not congregate at DCs, refuting the hypothesis
that DCs attract T cells (Miller et al., 2004a). DCs secrete chemokines and growth factors,
but the yield of these molecules is low in comparison to that of FRCs (Cyster, 1999; Luther
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et al., 2000). Additionally, it is unknown how far chemokines diffuse from the producing
cell, and whether any measurable gradient of chemokine exists within the paracortex. In
vitro experiments have shown that DC-produced chemokines can induce directional
motility of T cells, but this is challenging to demonstrate in situ. There is debate over what,
if anything, promotes directional motion of T cells to DCs in vivo. Additionally, it is
possible that DCs are merely positioned so other cell types can directly promote funneling
of T cells to DCs for organized scanning.
The cellular and structural components described above may facilitate motility in
different ways. Chemokines produced by FRCs and DCs may stimulate motility directly.
Growth factor or cytokine signaling may stimulate metabolism to fuel requirements for
motility. Surfaces of cells and structures may be mechanosensed by T cells and induce
friction-based motion. Our understanding of the relative contributions of each of these
proposed mechanisms to naïve T cell motility in the LN remains incomplete.
1.2. Microscopy in biomedical research
1.2.1. 2 photon microscopy
The first in situ observations of T cell motility within intact LNs were published in
2002 (Cahalan et al., 2002; Miller et al., 2002; Stoll et al., 2002) and showed the power of
2 photon microscopy (2PM) for imaging intact tissue and native cell behavior. The gap in
time between the first microscope images of cell motility and microscopy of motile T cells
in intact organs is in part due to toxicity of dyes for live cells, photobleaching of dyes by
fluorescent lamps and lasers, and light scattering within tissue leading to poor signal to
noise.
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Advances in fluorescence microscopy reagents and the advent of 2 photon
microscopy have addressed the above-mentioned difficulties. Less toxic and more
photostable fluorophores have been developed, and the concept of 2 photon absorbance
coupled with microscopy was shown in 1990 (Denk et al., 1990). 2 photon microscopy
(2PM) involves a laser beam split into two beams, and the two beams are focused at the
same point. The two beams pulsing infrared light each contribute half the energy to excite
a single fluorescent molecule (Denk et al., 1990). Cells or proteins of interest express are
labeled with a fluorescent molecule (fluorophore) that emits visible light and can be
captured by photon detectors, enabling visualization of fluorescently-labeled cells or
proteins. The concept behind using two beams with half the energy (i.e. approximately
twice the wavelength) to excite a fluorophore is that only the spot where the beams are
focused receives enough energy to excite and emit. This allows imaging of deeper planes
in tissue because of less light scattering (i.e. less background) and less photobleaching
(Cahalan et al., 2002). When serial planes are imaged, they can be reconstructed as a threedimensional volume. These stacks of image planes are called z-stacks, referring to twodimensional XY images stacked in the z direction, and the same z-stack can be imaged
sequentially to obtain a time series of a three-dimensional field. These videos of
microscope fields can be analyzed to understand how the fluorescent cells move and
interact with the environment within tissues.
1.2.2. Microscopy image analysis
1.2.2.1. Qualitative colocalization or behavior characterization
In the early days of time-lapse 2PM, cell localization analysis consisted of visual
inspection and qualitative characterization of cell behavior changes. Cells that appeared to
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be in close proximity to other cells or stromal structures within tissues were broadly
described as intercellular contacts. For example, Bajenoff et al. published images of T cells
appearing in close proximity with the FRC network and correlated the directions of T cell
turns to the direction of FRC fibers (Bajénoff et al., 2006). This qualitative inspection has
significant value in identifying general cell behaviors, such as if one cell type broadly
occupies a compartment that is spatially distinct from another cell type, or whether a cell
can move from one barricaded compartment to another. This type of analysis is adequate
for answering questions of whether a cell can perform a function, but it does not
quantitatively determining how often cells perform a certain behavior or how likely one
cellular event is to lead to a specific outcome. Quantitative measurements and analyses are
required for a better understanding of cell biology in situ.
1.2.2.2. Tracking or measurements and statistics
Reproducible tracking of cells over time became possible with software algorithms
that identify centroids of cell bodies based on pixel fluorescence quality (or other
parameters such as median fluorescence intensity or cell center) and record cell position
across all frames of a time-lapse imaging sequence. The coordinates of cell position
together with time information can be used to assess velocity, patterns of cell motility,
location relative to other tracked objects, and numerous other parameters. Measurements
of cell boundaries or distances of cells to other features can also be computed. Data of these
parameters allow for quantitative analysis of cell motility and localization. Statistical tests
on these parameters must be carefully chosen, as motility data is rarely normally
distributed. For example, spermatozoa, fibroblasts, bacteria, mitochondria, and T cells have
all been reported to have non-Gaussian motility distributions (Kandel et al., 2015; Kipper
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et al., 2007; Letendre et al., 2015; Liang et al., 2018; Martínez-Pastor et al., 2011). In our
studies, we use non-parametric statistical tests to address this issue.
1.2.2.3. Quantitative approaches to analyzing intercellular interactions
T cell motility data combined with spatial data of T cell interactions with other cells
in the LN can inform the mechanisms underlying T cell search for antigen. Robust
analytical tools are required to make quantitative conclusions about spatial data from
microscopy images. To determine whether two cells or two molecules might interact
spatially, the need to measure colocalization, cell clustering, dimerization, etc. in
biomedical imaging motivates tool development in both the corporate and academic
sectors. Microscopy analyses that measure colocalization of fluorophores are often single
molecule or protein-protein correlation algorithms. These algorithms measure the amount
of fluorescence overlap in two channels at the resolution of a pixel. It is important to note
that correlation measures the co-occurrence of fluorescence in two different channels and
considers the fluorescence intensity of the two probes. The most common correlation
statistics and their limitations are introduced here.
Pearson correlation coefficient (PCC) is a standard tool used to assess
colocalization in microcopy images. PCC as it pertains to microscopy is a measure of
covariance of fluorescence intensities of two channels, i.e. the mean intensity of each
channel is subtracted from the pixel intensity of the corresponding channel (Equation 1)
(Dunn et al., 2011; Manders et al., 1992). PCC is generally robust in that it is independent
of signal levels and does not require preprocessing. Despite this, preprocessing is often
performed on images prior to calculating. Regions-of-interest (ROIs) are often defined so
the heterogeneity of the image does not affect the correlation in a way that is not
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representative of the biology. For instance, consider a case in which subcellular proteins
fluoresce in an image of multiple cells in a dish. There is negative space between the cells,
and this negative space contains pixels with low intensity in both channels. Though the
extracellular negative space is not of interest, performing PCC over the whole image
includes it. Thus, the correlation of the two fluorophores is increased due to the two probes
never co-occurring in the negative space. In this case, it is advisable to draw ROIs around
individual cells and perform PCC on only the parts of the image where it is possible for the
fluorophores to co-occur.
PCC assumes a linear relationship between fluorophore distribution (Dunn et al.,
2011). Linearity between fluorophores is not guaranteed in biomedical data. Even in
images of homogeneous cell lines, there can still be differential expression of probes across
cells or within the same cell in multiple compartments. PCC may be inadequate for
assessing colocalization when fluorophores have different distributions in intensity and
spatial occurrence. For example, if a red fluor is abundant and clustered in one quadrant of
the image and sparse and uniformly distributed in another quadrant of the image, and the
second fluor co-occurs with the first fluor differently (in abundance or intensity) in the two
quadrants, these probes would not fit a linear relationship. As PCC is typically used in
biomedical imaging applications to measure correlation between subcellular structures, this
non-linear relationship could occur in a field containing multiple cells with heterogeneous
expression/labeling of each of the two probes. For this situation, ROIs can be drawn around
individual cells. When using PCC to measure correlation of whole cells with other cells or
structures in tissue (rather than subcellular probes), in situ cells may have heterogeneous
localization
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Mander’s overlap coefficient (MOC) is similar to PCC in that it is a pixel based metric, but
it does not measure the covariance of pixel intensity. MOC measures whether there is
positive signal in both channels without considering the intensity, and it is the proportion
of total pixels that have positive signal in both (Adler and Parmryd, 2010; Manders et al.,
1993). This may be useful when it is known that the fluorescence intensity of a fluor varies
non-linearly with the fluorescence distribution of the second fluor, but it can lead to
misleading results of high MOC values in fluorescence images in which there is
background noise. Artificially high MOC values can be avoided by implementing
thresholding for positive signal determined subjectively. Many colocalization methods
allow for setting thresholds of fluorescence intensity in order to differentiate positive signal
and background signal, though this can result in user-created bias.
PCC, MOC, and other pixel-based measures of colocalization are routine in
microscopy studies and are available in some form in every image processing software
packages. However, use of these methods require careful consideration as to whether they
are appropriate for analyzing the content of the image. PCC, MOC, and other correlation
coefficients are unfit for measuring intercellular relationships in images of tissue due to the
metrics being reliant on linearity (PCC) and pixel-based (both PCC and MOC).
Pixel-based measures may fail to capture intercellular colocalization. Because two
discrete cells cannot occupy the same physical space, any overlap in fluorescence at the
pixel level is an artifact of image resolution. Two cell types can still be correlated if they
reliably localized near each other relative. For example, cell A and cell B are consistently
observed 5 µm away from each other, whereas cell types C and D vary widely in their
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distance to cells A or B. The correlation between cells A and B would not be captured by
pixel-based measures because the cells are not sharing any fluorescence overlap. A tool to
measure intercellular relationships in tissue would be valuable but is not readily available.
1.2.2.4. Mutual information
An alternative to direct pixel-based measures of correlation comes from mutual
information in computational domains. Mutual information (MI) is a component of
Shannon information theory and has been used for image registration in biomedical
imaging such as magnetic resonance, computerized tomography, and positron-emission
tomography images (Maes et al., 1997; McLaughlin et al., 2004; Studholme et al., 1997;
Wilkie and Vrscay, 2005; Yokoi et al., 2004). MI is a measure of how much dependence
exists between two random variables (Cover and Thomas, 2012), and can be translated for
use with microscopy images to determine if two random variables, for example, fluorescent
microscopy images in which two fluorophores associated with different cell types are
colocalized. The basic MI calculation involves summing the entropy of two random
variables and subtracting the joint entropy, or the entropy of both of the random variables
occurring together (Equation 2). Entropy here means the uncertainty of an event occurring.
Thus, the information shared between two random variables is the sum of the likelihood of
two events occurring independently and subtracting out the likelihood of the two events
occurring together. In Chapter 3, we have developed a methodology to adapt MI for 2PM
image analysis to quantify the amount of association between T cells and other cell types
in the LN paracortex.
1.3. Summary
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Many studies have contributed to our current understanding of the mechanisms
driving naïve T cell dynamics in the LN paracortex, several key questions remain
unanswered. While T cells move seemingly randomly in the paracortex, there are cells and
structures that produce molecular mediators that we know influence motility. When these
molecules are knocked out or inhibited, T cells still move within the paracortex with
residual speed. Whether additional molecules and factors contribute to T cell motility is
unknown. These same cell types also confine T cell motion and/or provide contact
guidance, but whether these interactions are associated T:DC interactions and subsequent
T cell activation is unexplored. Building on the observation by Saini et al. that naïve T cell
activation is hindered in the absence of IL-7R signaling in vivo (Saini et al., 2009), we
investigate in Chapter 2 whether IL-7 promotes T:DC interactions in the lymph node by
inducing naïve T cell motility. We show that IL-7 indeed promotes T cell motility via the
JAK/STAT pathway and, in a computation model of the LN, was shown to promote DC
scanning by increasing the number of novel DC contacts. In Chapter 3, we develop a
method that uses mutual information to determine which cell type is most closely
associated with T cells in the LN paracortex. We find T cells are most associated with the
FRC network relative to the DCs and the vasculature, supporting the hypothesis that T cells
use the FRC network for motion. However, association with FRCs does not correlate with
association with DCs, suggesting there is still randomness in the T cell search for antigen,
i.e. not all cell types are organized along the FRC network for optimal T cell priming.
Taken together, this work identifies a new role for IL-7 as a regulator of naïve T cell
motility and provided a quantitative approach to characterizing intercellular associations
within the LN paracortex.
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CHAPTER 2: A novel role for IL-7R in promoting naïve T cell motility to enable T
cell scanning of dendritic cells in the LN
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2.1. Abstract: IL-7 is a key regulator of T cell survival and priming in lymph nodes (LNs),
and has been shown to be important for enhancing T cell activation in vivo but not in vitro.
The mechanism by which IL-7 promotes T cell activation in vivo is still not fully
elucidated. Using 2 photon microscopy we find a novel role for IL-7 in regulating high
speed T cell motion within lymph nodes. Downstream of IL-7R, T cell motility requires
JAK/STAT activation but not mTOR signaling. Interestingly, we find that IL-7R signaling
modulates CCR7 expression and IL-7R converges with CCR7 signaling leading to high
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speed T cell motility. Both direct measurement of T cell-dendritic cell (DC) distance and
computational modeling demonstrate that decreased T cell motility in the absence of IL7R decreases T cell localization near DCs in the LN, suggesting that IL-7 drives high speed
T cell motion which promotes T-DC interactions leading to T cell activation. Our findings
demonstrate a previously unidentified role for the IL-7/IL-7R pathway in controlling T cell
motility via modulation of CCR7, showing that IL-7/IL-7R mediated T cell motion
increases T cell-DC interactions in the LN, leading to effective T cell responses in vivo.

2.2. Introduction
Interleukin 7 (IL-7) is a cytokine fundamental to T cell development, survival, and
proliferation. IL-7 is produced by both dendritic cells (DCs) and stromal cells in lymph
nodes (LNs); in particular, fibroblastic reticular cells (FRCs) produce IL-7 in quantities
that support T cell homeostasis (Link et al., 2007) and drive LN architecture remodeling
(Onder et al., 2012). After development, IL-7 is needed for efficient naïve T cell receptor
triggering during homeostatic proliferation and antigen-induced activation. IL-7R
expressed on naïve T cells signals through receptor-associated JAK1 and JAK3 leading to
STAT activation (Crawley et al., 2014; Ghoreschi et al., 2009). The JAK/STAT pathway
is essential for cytokine signaling, and JAKs activate the STAT family of transcription
factors by phosphorylation and regulate hematopoiesis, growth, survival, differentiation,
and inflammatory response signaling (Fry and Mackall, 2005; Guo et al., 2010; Jacobs et
al., 2010a; Maraskovsky et al., 1996). IL-7R-mediated JAK/STAT signal transduction in
T cells results in survival and proliferation effects (Crawley et al., 2014; Fry and Mackall,
2005; Guo et al., 2010; Jacobs et al., 2010a; Maraskovsky et al., 1996; Saini et al., 2009).
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mTOR and PI3K/Akt have also been shown to act downstream of IL-7R to mediate T cell
survival (Chi, 2012; Rathmell et al., 2001).
While it is clear that IL-7 is crucial for T cell function, the precise mechanism of
how IL-7 regulates T cell activation in vivo is still not known. Interestingly, absence of IL7R signaling on naïve T cells does not appear to affect in vitro TCR signaling, however,
depletion of IL-7R in vivo leads to significant defects in T cell activation (Maraskovsky et
al., 1996; Saini et al., 2009). This discrepancy suggests that IL-7 is likely to exert effects
on T cell function in the in vivo context other than direct effects on TCR-mediated
activation. One possible mechanism for the in vivo contextual effect of IL-7 on T cell
activation is that IL-7 may promote spatial proximity of T cells to antigen presenting cells
through motility modulation. IL-7 levels are high in LNs, but whether IL-7 and associated
downstream signaling might play a role in promoting naïve T cell motility in addition to T
cell survival in LNs has not been investigated.
In the absence of infection, T cells continually scan the surface of DCs searching
for cognate antigen, moving apparently randomly with directional persistence and a
lognormal distribution of step sizes in order to contact DCs (Fricke et al., 2016; Miller et
al., 2002, 2004b). This baseline motility is enabled by multiple molecules which contribute
to the chemokinetic effect on T cell motility within the T cell zone, including CCL21, the
ligand for CCR7 on T cells (Asperti-Boursin et al., 2007; Worbs et al., 2007),
lysophosphatidic acid (LPA) interacting with LPA receptors on T cells (Katakai et al.,
2014; Zhang et al., 2012), as well as LFA-1 (Katakai et al., 2013). CCL21 and LPA are Gprotein-coupled receptor ligands produced by stromal cells to induce T cell motion (Hauser
and Legler, 2016; Hwang et al., 2007; Katakai et al., 2014; Knowlden et al., 2014). CCL21
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(and CCL19) can be transported to the HEV lumen by lymphatic conduits and presented
to T cells to chemotactically mediate LFA-1-activation and transendothelial migration to
the paracortex (Palframan et al., 2001; Stein et al., 2000). Within the paracortex, CCL21
enables high speed motility independent of ICAM-1-LFA-1 interactions (Woolf et al.,
2007). Recently, LPA was characterized as inducing T cell motility in the LN and
enhancing transendothelial migration (Katakai et al., 2014; Knowlden et al., 2014; Zhang
et al., 2012). However, nothing is known about whether other molecules such as IL-7 may
contribute to high speed T cell motility.
In this study, we investigate the mechanism by which IL-7 facilitates T cell
activation in the in vivo lymph node context. We find that IL-7 plays a key role in driving
naïve T cell motion in LNs. Using 2 photon microscopy (2PM) to visualize T cell motility
in LNs, we show that IL-7 is required for high speed T cell motility in LNs. Downstream
of IL-7R, JAK1 and JAK3 as well as STAT5, but not mTOR, regulate T cell motion. We
show that IL-7R likely mediates effects on T cell motion by converging on the CCR7
signaling pathway. Importantly, inhibition of IL-7/IL-7R signaling leads to significant
decreases in baseline T cell contacts with DCs, suggesting that IL-7 is a crucial mediator
of T-DC interactions to promote naïve T cell scanning of DCs within LNs.
2.3. Results
2.3.1 IL-7 regulates CCR7 expression but is dispensable for T cell homing to the LNs
As IL-7 has not been previously implicated in T cell migration and motility, we
first asked whether IL-7 participates in naïve T cell homing to LNs. To do this, we isolated
total GFP+ splenocytes and incubated with anti-IL-7R antibody and then transferred IL7R-blocked splenocytes into mice treated with anti-IL-7 antibody. After 4.5 hours,
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peripheral blood and secondary lymphoid organs (SLOs) were assessed for homing of
specific T cell subsets as well as B cells to SLOs in the absence of IL-7/IL-7R signals. We
measured the effect of antibody treatment on T cell surface expression of IL-7R within IL7/IL-7R blocked mice using flow cytometry. In the LNs and the spleen, anti-IL-7R-treated
GFP+ T cells exhibited lower IL-7R expression in anti-IL-7-treated animals compared to
isotype-treated animals (Fig. 2.1a-b; LN p = 0.0013, spleen p = 0.0005). We then compared
homing of IL-7R-blocked T cells in anti-IL-7 treated animals to isotype-blocked T cells in
isotype-treated animals. We found no significant difference in the number of IL-7/IL-7Rblocked T cells (CD3+GFP+) or B cells (CD19+GFP+) in SLOs, spleen or blood compared
to isotype-treated animals (Fig. 2.1c-df). Homing of GFP+ CD4+ and CD8+ T cell subsets
to SLOs was similar relative to total CD4+ and CD8+ subsets (data not shown). These
results show that total T cell migration to LNs was not changed in the absence of IL-7/IL7R signaling.
A previous study has implicated CCR7 in IL-7R responses, so we assessed CCR7
expression in IL-7/IL-7R blocked T cells (Jung et al., 2010). Cell surface staining revealed
transferred IL-7/IL-7R blocked T cells in the LNs and spleen expressed significantly lower
CCR7 levels compared to T cells from isotype-treated mice in lymph nodes and we saw a
similar same trend for T cells from the spleen (Fig. 2.1e-f; LN p = 0.0037, spleen p =
0.0907). These results indicate that IL-7R signaling can regulate CCR7 expression,
however, the decrease in CCR7 expression does not result in decreased T cell homing from
blood into LNs.
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Figure 2.1. IL-7 regulates CCR7 expression but not homing of naïve T cells to lymph
nodes. Naïve mice received either anti-IL-7 or isotype control via IP injection on days -3
and -1. On day 0, GFP+ splenocytes were treated with isotype antibody or anti-IL-7R (10
µg mL-1) antibody and adoptively transferred into the antibody-treated (called “Anti-IL-7
+ Anti-IL-7R”) or isotype-treated (called “Isotype”) mice. After 4.5 hours, recipient mice
were sacrificed and GFP+ T cells in LNs, spleen, and blood were counted using flow
cytometry. Data for isotype-treated animals are in white bars and anti-IL-7/IL-7R-treated
animals in black. (A) Histogram of MFI of IL-7R expression in CD3+GFP+ population in
LN. (B) IL-7R MFI of CD3+GFP+ population in LN and spleen. Two-tailed student's T
test p values are shown. (C) Representative gating strategy for GFP+ cells in CD3+
population for LN, spleen, and peripheral blood for both anti-IL-7 + anti-IL-7R treated
mice and isotype-treated mice. (D, left) Percent of CD3+GFP+ events counted in LN,
spleen, and peripheral blood. Two-tailed student's T test are indicated. (D, right) Percent
of CD19+GFP+ events counted in LN, spleen, and peripheral blood. Two-tailed student's
T test are shown. (E) Histogram of MFI of CCR7 expression in CD3+GFP+ population in
the LN. (F) MFI of CCR7 expression in CD3+GFP+ population in LN and spleen in
antibody-treated mice (mean MFI value across 3 samples = 896) and isotype-treated mice
(mean MFI value across 3 samples = 459). Two-tailed student’s T Test is shown. Data from
a single experiment representative of 2 independent experiments with 3 mice in each
condition (total n = 6 mice per condition).
2.3.2. IL-7 promotes T cell motility in the LN
We then asked whether IL-7 might affect T cell motion within LNs using timelapse 2PM of LN explants. Total CD3+ T cells were isolated from naïve Ubiquitin-GFP
mice or from naïve C57BL/6 mice then labeled with CMTMR, and adoptively transferred
into naïve C57BL/6 recipients. LNs were harvested one day later and imaged for a duration
of up to 4 hours. Labeled naïve T cells were visualized and tracked before and after addition
of anti-IL-7 and anti-IL-7R antibodies. T cells showed significantly reduced mean track
speeds after ~20 minutes of IL-7/IL-7R inhibition by antibody addition (Fig. 2.2a, Movie
S1; median of before antibody addition = 6.7 µm min-1, median of after antibody addition
= 4.8 µm min-1, p < 0.0001). After antibody addition, the arrest coefficient, or the percent
of time a cell moves slower than 2 µm min-1, significantly increased (Fig. 2.2b; median of
before experiments = 8.5, median of after experiments = 20, p < 0.0001). Track straightness
was evaluated to determine the effect of IL-7/IL-7R blockade on directional persistence.
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Track straightness, as measured by a confinement ratio, did not change after antibody
addition (Fig. 2.2c; median = 0.41, p = 0.4169), but the fraction of track time a T cell spent
moving a distance of less than 5 µm (idle time) was greater after antibody blockade (Fig.
2.2d; median of before experiments = 0.2334, median of after experiments = 0.3847, p =
0.0184). These data indicate that IL-7 promotes T cell motility in the LN, and that IL-7/IL7R inhibition dramatically decreases T cell speed and displacement without changing the
confinement or straightness patterns of T cell tracks.

Figure 2.2. IL-7 is required for high speed T cell motility in lymph nodes. CD3+
T cells were isolated from GFP+ mice and adoptively transferred into naïve mice, or T cells
were isolated from C57Bl/6 mice and labeled with CMTMR and then adoptively
transferred into naïve mice. The following day, LNs were harvested, kept intact, and
superfused with media during imaging by 2PM. Partway through imaging, antibodies
against IL-7 and IL-7R were added to the superfused media and imaging continued. Each
time-lapse z-stack was acquired for 15-45 minutes. Data are pooled from 3 experiments on
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3 days, imaging multiple lymph nodes from a single mouse in each experiment. T cells in
movies were tracked with semi-automated tracking with manual editing, with no filtering
for minimum displacement (Imaris; Bitplane, Inc.). Before n = 554 T cells, After n = 355
T cells. (A) Violin plots of mean track speeds of individual T cells before (black) and after
(grey) addition of anti-IL-7 and anti-IL-7R. Median (open circle; Before = 6.7 µm min-1,
After = 4.8 µm min-1), interquartile range (grey bars) and full range (grey line) are
depicted. The shape of the violin is the kernel density estimate of the mean track speeds.
Mann Whitney p value < 0.0001. (B) Arrest coefficient (proportion of time a T cell track
is <2 µm min-1; Mann Whitney p value < 0.0001), (C) confinement ratio (track
displacement divided by track length; Mann Whitney p value = 0.4169), and (D) fraction
of track time moving fewer than 5 µm for before and after antibody addition (Mann
Whitney p value = 0.0184). (B-D) Median (black line), 95% confidence interval around
median (boundaries of notch), interquartile range (box), full range (whisker), and outliers
(crosses) are shown.
2.3.3. JAK-STAT signaling is critical for intranodal T cell motility
IL-7R signals via JAK/STAT activation as well as mTOR resulting in survival and
proliferation effects (Chi, 2012; Rathmell et al., 2001), but whether these same pathways
connect IL-7R to T cell motility is unexplored. To ask whether JAK/STAT pathways also
regulate T cell motility in LNs, we utilized commercially available and well-studied
inhibitors of the JAK/STAT pathway. We used 2PM to image explanted LNs with
transferred fluorescent naïve CD3+ T cells and treated LNs with Ruxolitinib (Rux; panJAK inhibitor) to determine the effect of JAK inhibition on T cell motility in the LN. Rux
treatment resulted in a striking reduction in T cell mean track speeds (Fig. 2.3a, Movie S2;
median track speed of 8.9 µm min-1 before treatment compared to 5.6 µm min-1 after Rux
treatment, p < 0.0001). We then asked whether JAK3 is specifically involved in regulating
T cell motility by treating LNs with Tofacitinib, a JAK3 inhibitor (Changelian et al., 2003;
Flanagan et al., 2010). Tofacitinib treatment resulted in a more modest, but still significant
reduction in T cell track speeds (Fig. 2.3b, Movie S3; median track speed of 6.1 µm min-1
before treatment compared to 5.2 µm min-1 after Tofa treatment, p < 0.0001). These results
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show that JAKs are key effectors downstream of IL-7R signaling mediating T cell motion
in LNs.
Downstream of JAK phosphorylation, IL-7R signaling activates STAT5, which is
crucial for long-term naïve T cell survival (Hand et al., 2010; Seki et al., 2007). To
determine the effect of STAT5 on naïve T cell motility in the LN, we inhibited STAT5 in
our explant 2PM system using 2-[(4-oxo-4H-1-benzopyran-3-yl)methylene]hydrazide 3pyridinecarboxylic acid, hereafter referred to as STAT5 inhibitor. Treatment of LN
explants with STAT5 inhibitor resulted in a profound reduction in T cell track speeds
within 25 minutes (Fig. 2.3c, Movie S4; median track speed 7.7 µm min-1 before treatment
compared to 2.3 µm min-1 after treatment, p < 0.0001). STAT5 inhibition consistently
caused a more pronounced reduction in motility than IL-7 and IL-7R inhibition, suggesting
that multiple signals may activate STAT5 to promote T cell motility. These results
demonstrate that JAK1/3 activation of STAT5 is necessary for T cell motility in the LN.
IL-7R signaling to JAK/STAT pathway provides a novel pathway that can regulate rapid
T cell migration in LNs.
2.3.4. IL-7 effects on T cell motility are not mediated by mTOR activation
mTOR complexes are associated with RhoA-ROCK-mediated motility in cancer
invasion and metastasis, neutrophil and macrophage chemotaxis, and in vitro chemokinemediated migration of T cells (Hashimoto et al., 2008; He et al., 2013; Munk et al., 2011;
Murooka et al., 2008; Wang et al., 2008). IL-7 is a known metabolic regulator via activation
of mTOR (Cui et al., 2015; Jacobs et al., 2010a; Rathmell et al., 2001; Saini et al., 2009;
Wofford et al., 2008). Further, IL-7 can activate mTOR in double-negative T cells
(Allgäuer et al., 2015), suggesting that IL-7R may activate mTOR and metabolic pathways
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to enhance T cell motion. We asked whether mTOR influences naïve T cell motility in situ
by inhibiting either mTORC1 or both mTORC1/2 with rapamycin and PP242, respectively.
Unexpectedly, inhibiting mTOR via PP242 or rapamycin resulted in a slight, but significant
increase in naïve T cell motility (Fig. 2.3d left panel, median track speed mean before
PP242 addition = 6.6 µm min-1, median track speed mean after PP242 addition = 7.98 µm
min-1, p < 0.0001; Fig. 2.3d right panel, median track speed mean before rapamycin
addition = 3.2 µm min-1, median track speed mean after rapamycin addition = 6.16 µm
min-1, p < 0.0001, Movie S5). These data indicate that in naïve T cells, mTOR actually
restrains T cell movement. Other studies have shown that while activated CD4+ T cells
require mTOR activation for in vivo migration (Haas et al., 2015), Treg cell migration is
unaffected by mTOR inhibition (Kishore et al., 2017). Thus, it is likely that there are
multiple mechanisms regulating mTOR effect on T cell motility in different activation and
differentiation states.
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Figure 2.3. JAK/STAT signaling, but not mTOR, regulates T cell movement in LNs.
CD3+ T cells were isolated from GFP+ mice and adoptively transferred into naïve mice,
or T cells were isolated from C57Bl/6 mice and labeled with CMTMR and then adoptively
transferred into naïve mice. The following day, LNs were harvested, kept intact, and
superfused with media during imaging by 2PM. Part way through imaging, JAK/STAT
inhibitor (Ruxolitinib (A), Tofacitinib (B), or STAT5 inhibitor (C)) were added to the
superfused media and imaging continued. Each time-lapse z-stack was acquired for 15-45
minutes. T cells in movies were tracked with semi-automated tracking with manual editing,
with no filtering for minimum displacement (Imaris; Bitplane, Inc.). (A-C) T cell track
speeds before and after addition of Ruxolitinib (1 µM; A), Tofacitinib (1 µM; B), or STAT5
inhibition (50 µM; C). (A) Before Rux addition, median track speed mean = 8.9 µm min1 (n = 408 tracks). After Rux addition, median track speed mean = 5.6 µm min-1 (n = 287
tracks). Tracks were pooled from 2 separate experiments on 2 different days. Mann
Whitney test p value < 0.0001. (B) Before Tofa addition, median track speed mean = 6.1
µm min-1 (n = 1027 tracks). After Tofa addition, median track speed mean = 4.9 µm min1 (1092 tracks). Tracks were pooled from 3 separate experiments on 3 different days. Mann
Whitney test p value < 0.0001. (C) Before STAT5 inh addition, median track speed mean
= 7.7 µm min-1 (n = 1749 tracks). After STAT5 inh addition, median track speed mean =
¸2.3 µm min-1 (n = 695 tracks). Tracks were pooled from 2 separate experiments on 2
different days. Mann Whitney test p value < 0.0001. (D, left) T cell track speed means
before and after addition of PP242 (1 µM). Median track speed mean before PP242 addition
= 6.6 µm min-1 (n = 917), median track speed mean after PP242 addition = 7.98 µm min1 (n = 907). Mann Whitney test p value < 0.0001. Tracks from 2 experiments on 2 different
days. (D, right) T cell track speed means before and after addition of rapamycin (100 ng
mL-1). Median track speed mean before rapamycin addition = 3.2 µm min-1 (n = 199),
median track speed mean after rapamycin addition = 6.16 µm min-1 (n = 1500). Mann
Whitney test p value < 0.0001. Tracks from 2 experiments on 2 different days. (E) GTPbound RhoA in response to CCL21 (1 µg/mL), IL-7 (10 ng/mL) or untreated media as
measured by G-LISA 2 minutes after addition of cytokines. Data representative of 4
experiments. Two-tailed student’s T test performed on data from CCL21 treatment (p value
= 0.0008) and IL-7 treatment (p value = 0.0114) relative to untreated control.
We then investigated the role of IL-7R signaling to cytoskeletal regulators of T cell
motion. Rho GTPases are established in many cell types as regulators of actin cytoskeleton
reorganization leading to polarization and motility (Monypenny et al., 2009; Mrass et al.,
2017; Pernis, 2009; Ridley, 2015). In naive T cells, RhoA activation is essential for CCR7and LPAR-mediated motility (Giagulli et al., 2004; Saoudi et al., 2014). In the case of
CCR7 signaling, JAK3 activity is needed for RhoA activation (Ambriz-Peña et al., 2014).
In smooth muscle cells, Rho family activation is required for STAT activity (Pelletier et
al., 2003). Due to the crosstalk among RhoA and JAK/STATs in T cells and other cell

39

types, and the precedent of RhoA activation in T cell chemokine signaling, we
hypothesized RhoA might regulate T cell motion downstream of IL-7R. In agreement with
this hypothesis, we found that IL-7 activated RhoA in in vitro activated primary murine T
cells as measured by GLISA similar to levels seen upon CCL21 activation (Fig. 2.3e, p =
0.0114). These results show that IL-7R signals to JAK/STATs and RhoA but not mTOR
to mediate high speed T cell motility in LNs.
2.3.5. IL-7R and CCR7 signaling converge to control T cell speed in the LN
Several extracellular signals have been shown to mediate naïve T cell motility in
LNs, including CCL21 and LPA, which both signal to RhoA leading to T cell motion. We
now find that IL-7 can also induce T cell motility via RhoA activation (Fig. 2.3e). While
both CCL21 and LPA induce T cell motility within LNs, it is clear that additional signals
play a role as T cells still have residual motility capability in the absence of CCR7 and LPA
receptor (LPAR) (Asperti-Boursin et al., 2007; Hauser and Legler, 2016; Katakai et al.,
2014; Knowlden et al., 2014; Takeda et al., 2016; Tanikawa et al., 2010; Worbs et al., 2007;
Zhang et al., 2012). CCR7-/- T cells exhibit reduced speed compared to WT T cells, but
still move within the LN at ~5 µm min-1 (Asperti-Boursin et al., 2007; Worbs et al., 2007).
LPA produced by FRCs induces T cell motility in the LN, but inhibiting LPA results in
only a 20% reduction in speed (Katakai et al., 2014; Takeda et al., 2016; Tanikawa et al.,
2010). One unresolved question is whether IL-7R acts in conjunction with known
chemokine receptor signaling to promote motility.
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Figure 2.4. CCR7 and IL-7R function together but independently of LPAR to induce
T cell motility. CD3+ T cells were isolated from C57Bl/6 mice or CCR7-/- mice and
labeled with CMTMR, then adoptively transferred into naïve mice. The following day, LNs
were harvested, kept intact, and superfused with media during imaging by 2PM. Partway
through imaging, antibody against IL-7, LPAR inhibitor (Ki16425), or both anti-IL-7 and
Ki16425 were added to the superfused media and imaging continued. Each time-lapse zstack was acquired for 15-45 minutes. (A) Wild-type T cell mean track speeds (n = 199)
relative to CCR7-/- T cell mean track speeds (n = 263). WT median = 7.4 µm min-1, CCR7/- median = 4.9 µm min-1. Mann Whitney test p value < 0.0001. (B) CCR7-/- T cell mean
track speeds before (n = 137) and after (n = 279) anti-IL-7 antibody addition (10 µg/mL).
CCR7-/- median = 5.3 µm min-1, CCR7-/- after anti-IL-7 addition median = 5.1 µm min1. Mann Whitney test p value = 0.6166. (C) CCR7-/- T cell mean track speeds before (n =
55) and after (n = 51) addition of Ki16425 (LPA receptor antagonist; 25 µM). CCR7-/median = 4.3 µm min-1, CCR7-/- after Ki16425 addition median = 1.8 µm min-1. Mann
Whitney test p value <0.0001. (D) CCR7-/- T cell mean track speeds before (median = 4.5
µm min-1, n= 71) and after (median = 2.5 µm min-1, n = 158) addition of both anti-IL-7
and Ki16425 (10 µg/mL and 25 µM, respectively). Mann Whitney test p value < 0.0001.

We addressed the potential convergence of signals downstream of CCR7, LPAR,
and IL-7R by blocking CCR7, LPAR, and IL-7R in combination and then assessing T cell
motility. We co-adoptively transferred T cells from WT C57BL/6 (labeled with CFSE) or
CCR7-/- animals (labeled with CMTMR) into recipient mice, then used 2PM to track WT
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and CCR7-/- T cells in intact LNs (Letendre et al., 2015). In agreement with published
literature and our own work, CCR7-/- T cells show approximately 50% reduction in T cell
speed compared with WT T cells (Fig. 2.4a, p < 0.0001). To test how IL-7R and CCR7
interplay to drive T cell motion, we transferred CCR7-/- T cells into recipient animals, then
imaged LNs with 2PM before and after anti-IL-7 antibody addition as described previously.
Interestingly, CCR7-/- T cells show no change in mean speed after addition of anti-IL-7
treatment (Fig. 2.4b, p = 0.6166). We also found that there was no additional migration
induced by IL-7 when combined with CCL21 using in vitro migration assays (Fig. S.2.1).
These results suggest CCR7 and IL-7R converge on a similar downstream pathway to
control T cell movement.
We then asked whether LPAR exhibits crosstalk with either CCR7 or IL-7R in
signaling to T cell motility. We inhibited LPA in vivo with CCR7-/- T cells by adoptively
transferring isolated T cells from CCR7-/- mice, then using time-lapse 2PM to image T cell
motility in intact LNs before and after addition of LPAR inhibitor Ki16425. We found that
Ki16425 addition further reduced median track speed of naïve CCR7-/- T cells compared to
before inhibition (Fig. 2.4c; median track speed mean before Ki16425 addition = 4.6 µm
min-1, median track speed mean after Ki16425 addition = 2.1 µm min-1, p < 0.0001),
demonstrating that CCR7 and LPAR signal independently to drive T cell motion in LNs.
We then inhibited both IL-7R and LPAR signaling in CCR7-/- T cells. When LNs
containing CCR7-/- T cells were treated with both anti-IL-7 and Ki16425 together, the
reduction in the median of track mean speeds is similar to Ki16425 inhibition with CCR7deficiency (Fig. 2.4d; median before = 4.5 µm min-1, median after = 2.4 µm min-1, p <
0.0001). Together, these data indicate that while IL-7, CCL21, and LPA all significantly
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contribute to T cell motility in the LN individually, LPAR acts in a separate pathway from
IL-7R and CCR7 to drive T cell movement.
We next asked whether IL-7R signaling might directly modulate CCR7 signaling.
We hypothesized that Erk phosphorylation may be a point of convergence for both CCR7
and IL-7R as Erk phosphorylation is a proximal event in CCR7 signaling leading to cell
motility (Kobayashi et al., 2017). IL-7R signaling also signals to Erk phosphorylation in
concert with TCR triggering (Deshpande et al., 2013). We determined whether IL-7R
signaling can modulate CCR7 signaling by measuring Erk phosphorylation (p-Erk1/2+) in
DND-41 T leukemic cells after in vitro stimulation with CCL21, IL-7, and the combination
of CCL21 and IL-7. IL-7 treatment alone induced a slight but not significant increase in
Erk1/2 phosphorylation, while stimulation with CCL21 resulted in a significant increase of
3.6742 fold in p-Erk1/2 compared to unstimulated cells (Fig. S.2.2, p < 0.0001). IL-7
together with CCL21 slightly decreased p-Erk1/2 compared with CCL21 alone but this
change was not significant, (Fig. S.2.2, IL-7 + CCL21 median fold change of percent of pErk1+ cells = 3.4037, p-value comparing CCL21 and CCL21 + IL-7 treatments, p =
0.2628). These results show that while IL-7R can modulate CCR7 expression and
converges with CCR7 signaling leading to high speed T cell motility, IL-7R signaling does
not directly change Erk phosphorylation downstream of CCR7.
2.3.6. Computational modeling predicts IL-7 regulates T cell scanning of DCs
One key role for naïve T cell motility is to facilitate T cell search for cognate antigen
presented by DCs in the LN. We hypothesized that absence of IL-7R signaling leading to
decreased T cell motility in vivo could lead to decreased baseline T-DC interactions. We
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investigated whether IL-7-mediated effects on high speed T cell motility in LNs results in
the ability of naïve T cells to promote scanning of DCs under homeostatic conditions. Since
we find IL-7/IL-7R-blocked T cells move more slowly than WT T cells, we employed a
computational approach to estimate the effect of IL-7 blockade on the frequency of T-DC
contacts. A computational model was created in which empirical T cell tracks were
embedded in a simulated field with uniformly positioned “DC targets” to determine the
ability of T cells to contact DCs (Fricke et al., 2016). We calculated the total contacts with
all DCs as well as the number of unique DCs contacted with and without IL-7 signaling.
We found that there was only a slight decrease total number of T-DC contacts for T cells
after antibody blockade compared with total DC contacts before blockade (Fig. 2.5a, p =
0.049). In contrast, T cells made significantly fewer unique contacts after IL-7/IL-7R
blockade (Fig. 2.5b, p < 0.0001), indicating IL-7-induced motility may be critical for T
cells to efficiently cover a larger search area and scan numerous DCs in search of
potentially rare cognate antigen.

Figure 2.5. Computational modeling predicts IL-7 regulates T cell scanning of DCs.
CD3+ T cells were isolated from GFP+ mice and adoptively transferred into naïve mice,
or T cells were isolated from C57Bl/6 mice and labeled with CMTMR and then adoptively
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transferred into CD11c-YFP naïve mice. The following day, LNs were harvested, kept
intact, and superfused with media during imaging by 2PM. Partway through imaging,
antibodies against IL-7 and IL-7R were added to the superfused media and imaging
continued. Each time-lapse z-stack was acquired for 15-45 minutes. Data are pooled from
3 experiments on 3 days, imaging multiple lymph nodes from a single mouse in each
experiment. T cells in movies were tracked with semi-automated tracking with manual
editing, with no filtering for minimum displacement (Imaris; Bitplane, Inc.). T cell tracks
were fed into a simulator to quantify interactions with “DC targets” (A-B). (A) Total
contacts and (B) unique contacts made by T cells to simulated DCs (contacts min-1) before
and after addition of antibodies. Total Contacts median before treatment = 0.46 contacts
min-1, Unique Contacts median before treatment = 0.11 contacts min-1. Total Contacts
median after treatment = 0.43 contacts min-1, Unique Contacts median after treatment =
0.06 contacts min-1. Total contacts Mann Whitney test p value = 0.049. Unique contacts
Mann Whitney test p value <0.0001.

2.3.7. IL-7R signaling promotes interactions between T cells and DCs in the LN
To experimentally confirm the effect of IL-7 on the ability of T cells to scan for
target DCs in LNs, we calculated the volume covered by T cell tracks before and after
inhibition of IL-7-IL7R with blocking antibodies. Before antibody blockade, T cells
scanned a volume of approximately 7.7 µm3 s-1 compared to 5.7 µm3 s-1 after antibody
blockade (Fig. 2.6a; p = 0.0001). Given the model prediction that unique T-DC interactions
are influenced by IL-7 and that antibody-blocked T cells cover less volume, we directly
measured whether IL-7R signaling affects T cell proximity to DCs LNs visualized by 2PM.
We co-imaged T cells with DCs by labeling WT T cells with CMTMR and adoptively
transferring labeled T cells into CD11c-YFP mice (Lindquist et al., 2004). Using 2PM to
simultaneously visualize T cells and DCs in explanted LNs, we measured the distance
between T cell tracks and DCs in the LN before and after IL-7/IL-7R antibody blockade
(Movie S6). We found that T cells spent a greater proportion of individual track time closer
to DCs prior to antibody blockade (Fig. 2.6b, median percent of track time within 5 µm of
DCs before treatment = 83%, median after treatment = 45%, p = 0.001). These results
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suggest that high speed motility induced by IL-7R signaling can increase the likelihood of
T cell interaction with unique DCs within the LN.
We then asked whether DCs might directly recruit T cells via IL-7/IL-7R signaling
by calculating whether T cells “turn” towards DCs with IL-7/IL-7R signaling. We
determined whether T cells “turn” by calculating turning angles (TAs) of T cell tracks close
to DCs (i.e. within 25 µm) and far from DCs (i.e. any part of track ≥ 25 µm) before and
after IL-7/IL-7R antibody blockade. Smaller TAs close to DCs would indicate T cells are
“attracted” to DCs. If IL-7/IL-7R can recruit T cells to DCs, we would expect that blocking
IL-7/IL-7R would result in an increase of TA towards 90°, decreasing recruitment. We find
that before antibody blockade, TAs of T cells moving close to DCs were comparable to
TAs of T cells moving far from DCs (Fig. 2.6c; median close = 75.31°, median far = 71.80°,
p value = 0.1182). After antibody blockade, TAs changed but still did not show recruitment
(Fig. 2.6c; median close after = 78.79°, median far after = 59.20°, p value < 0.0001). While
TAs of T cells close to DCs were similar before and after antibody blockade (Fig. 2.6c;
median close before = 75.31°, median close after = 78.79°, p value = 0.3617), TAs of T
cells after antibody blockade were smaller only for T cells far from DCs. Thus, there does
not appear to be any active recruitment of T cells to DCs in LNs induced by IL-7, and in
fact, IL-7 may mediate T cell interactions with other cell types such as FRCs (Fricke et al.,
2016; Miller et al., 2004b; Tasnim et al., 2018a). Our results suggest that IL-7 leads to
increased likelihood of T cell encounters with DCs by promoting rapid T cell motility,
which is particularly important in sampling of unique DCs within LNs leading to T cell
activation.
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Figure 2.6. IL-7R signaling promotes interactions between T cells and DCs in the LN.
CD3+ T cells were isolated from GFP+ mice and adoptively transferred into naïve mice,
or T cells were isolated from C57Bl/6 mice and labeled with CMTMR and then adoptively
transferred into CD11c-YFP naïve mice. The following day, LNs were harvested, kept
intact, and superfused with media during imaging by 2PM. Partway through imaging,
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antibodies against IL-7 and IL-7R were added to the superfused media and imaging
continued. Each time-lapse z-stack was acquired for 15-45 minutes. Data are pooled from
3 experiments on 3 days, imaging multiple lymph nodes from a single mouse in each
experiment. T cells in movies were tracked with semi-automated tracking with manual
editing, with no filtering for minimum displacement (Imaris; Bitplane, Inc.). Volume
canvassed by T cell tracks was calculated (A). T cells from lymph nodes originating from
CD11c-YFP mice were analyzed for the percent of track time within 5 µm of DC (B). T
cell tracks were also divided into tracks close to DCs (< 25 µm) and far from DCs (≥ 25
µm) and their respective track turning angles were calculated (C). (A) Volume covered
(µm3 s-1) by T cell tracks in the T cell zone of the lymph node before (n = 431) and after
(n = 227) addition of anti-IL-7 and anti-IL-7R. Before median = 7.5 µm3 s-1, after median
= 5.8 µm3 s-1. Mann Whitney test p value = 1 x 10-04. (B) Violin plots of percent of
individual T cell tracks that are within 5 µm of dendritic cell fluorescence channel before
(grey) and after (black) addition of anti-IL-7 and anti-IL-7R. Median (open circle; Before
= 82.7%, After = 45.5%), interquartile range (grey bars) and full range (grey line) are
depicted. The shape of the violin is the kernel density estimate of the percent of track within
5 µm of DCs. Mann Whitney test p value = 0.0011. (C) Turning angles (in degrees) of T
cell tracks < 25 µm and ≥ 25 µm before and after addition of anti-IL-7 and anti-IL-7R.
Mann Whitney test p values are indicated.

2.4. Discussion
Naïve T cell motility facilitates T cell search for cognate antigen in the lymph node
which is important to determine the timing of T cell priming. We show a novel role for IL7 signaling to IL-7R in regulating high speed T cell motion in lymph nodes (Fig 2.2). Using
computational modeling and confirmed by experimental observation, we find that blocking
IL-7R signaling results in decreased T cell proximity to DCs, decreasing the likelihood of
T cell activation and priming (Fig. 2.6b). Previous observations had demonstrated IL-7 is
not required for T cell activation and proliferation in vitro, but is required for productive T
cell proliferation in vivo (Saini et al., 2009). Our data suggest that IL-7 likely regulates T
cell priming and proliferation in vivo not through direct effects on TCR signaling, but rather
by mediating the ability of T cells to move throughout the LN rapidly, resulting in enhanced
interaction rates with DCs. Thus, IL-7 mediated high speed motility of T cells improves
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the scanning efficiency of T cells in lymph nodes for new target DCs, enhancing the ability
of T cells to identify novel antigens to mount a more efficient T cell response.
We show that IL-7 can mediate T cell motility via both direct and indirect effects.
We find that IL-7 alone can activate RhoA, showing direct regulation of cytoskeletal
elements leading to T cell motion in lymph nodes. In contrast, we find that while IL-7R
signaling does not directly activate Erk phosphorylation or change CCR7-induced Erk
phosphorylation, IL-7R and CCR7 crosstalk through IL-7R regulation of CCR7 expression
(Fig. 2.1e). We find that the decreased CCR7 levels in the presence of short term IL-7 block
was not sufficient to block T cell homing to lymph nodes, but another recent study showed
that long term depletion of IL-7 blocks lymphocyte homing through depletion of ILC3
(59). Our results provide a mechanistic explanation for previous observations that IL-7R
expression levels are correlated with CCR7 function, with IL-7Rlo T cells migrating less in
response to CCL21 than IL-7Rhi T cells (Jung et al., 2010). Our results also fit with
evidence that IL-7 transcripts have been found in lymphatic endothelial cells (LECs) but
not blood endothelial cells, suggesting that IL-7 may not directly play a role in T cell entry
into LNs via HEVs (Malhotra et al., 2012; Miller et al., 2013). It is possible that inhibition
of IL-7R signaling leading to decreased CCR7 expression contributes to decreased T cell
motion. Interestingly, we show that LPAR exerts effects on T cell motion independent of
the IL-7R/CCR7 pathway, suggesting that multiple independent pathways can lead to high
speed T cell motion (Fig. 2.4b-d).
Our findings show that JAK/STAT signaling is a key mediator of T cell motility. It is likely
that both IL-7R and CCR7 signaling contribute to JAK/STAT activation, as CCR7 and IL7R have both been shown to signal via the JAK/STAT pathway (Crawley et al., 2014;
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García-Zepeda et al., 2007). We find that inhibition of JAKs including JAK1 and JAK3
results in a similar phenotype to IL-7-IL-7R blockade (Fig. 2.3). We also find that STAT5
is the likely effector downstream of JAK1/3 leading to T cell motion. The STAT family of
proteins has been shown to be activated by GPCRs and implicated in cancer cell migration
via microtubules and integrins (Gough et al., 2009; Silver et al., 2004; Teng et al., 2014;
Verma et al., 2009). Previously, Pelletier et al. identified Rho GTPases as a link between
GPCR signaling and STAT activation in smooth muscle cells (Pelletier et al., 2003), so the
profound motility reduction after STAT5 inhibition (Fig. 2.3c) may reflect an inhibition of
both a Gαi-dependent (e.g. CCR7 and LPAR) and Gαi-independent (e.g. IL-7R) regulation
of T cell motility in the LN. IL-7R to JAK/STAT pathway provides a novel pathway that
can regulate to rapid T cell migration and scanning of DCs in lymph nodes.
IL-7 is a known metabolic regulator via activation of mTOR (Cui et al., 2015;
Jacobs et al., 2010a; Rathmell et al., 2001; Saini et al., 2009; Wofford et al., 2008),
suggesting that IL-7R may activate mTOR and metabolic pathways to enhance T cell
motion. In contrast with this hypothesis, we show that inhibition of mTOR actually
increases the speed of naïve T cell motion (Fig. 2.3d). Interestingly, a recent study
demonstrated that mTORC2, but not mTORC1 regulates Treg cell migration (Kishore et
al., 2017). Canonical mTOR-mediated migration is via mTORC1, as smooth muscle cells,
epithelial cells, and cancer cells require mTORC1 activation to migrate (Liu and Parent,
2011). Our results showing increased naïve T cell motion using both rapamycin and PP242,
which inhibits both mTORC1 and mTORC2, suggests that for naïve T cells, mTOR
signaling restrains T cell movement. These data show that it is likely that there are multiple
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mechanisms that regulate the effect of mTOR on cell motility, and that mTOR may impact
cell motion differentially depending on the differentiation or activation state of the T cell.
In addition to naïve T cells, IL-7R has been shown to play a role in driving disease
phenotypes including solid tumors (Park et al., 2014) as well as T cell leukemias (Zenatti
et al., 2011). We have identified a novel role for IL-7 in regulating basal T cell motility,
leading to enhanced T cell scanning of DCs. Our results suggest that in addition to the
previously known role for IL-7 in regulating cell survival, IL-7 additionally enhances naïve
T cell migration. IL-7 has been previously shown to upregulate LFA-1 and VLA-4 and
enrich activated T cells at an inflamed site in a murine sepsis model (Unsinger et al., 2010),
as well as induce naïve T cell homing to the gastrointestinal tract via integrin upregulation
in mice (Cimbro et al., 2012). It remains to be determined whether IL-7 may also play a
role as a chemotactic factor for T cells in peripheral tissues in other tissue and infection
contexts.
2.5. Materials and Methods
2.5.1. Design
Homing experiments were performed similarly to that previously described (Mody et al.,
2007) by isolating and adoptively transferring labeled splenocytes into naïve hosts, and
assessing cell migration by flow cytometry. For 2-photon microscopy, labeled T cells were
adoptively transferred into recipients and explanted lymph nodes imaged and tracks
analyzed by Imaris (Bitplane) and MATLAB (Mathworks) (Cannon et al., 2013; Fricke et
al., 2016). The computational model of lymph nodes was built by T cell tracks captured by
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2PM and simulated dendritic cell targets added to the model and interactions counted
(Fricke et al., 2016).
2.5.2. Mice and reagents
C57BL/6 (Jackson Laboratories), Ubiquitin-GFP, and B6.129P2(C)-Ccr7tm1Rfor/J, and
B6.Cg-Tg(Itgax-Venus)1Mnz/J (stock #008829) mice were used. All mice were
maintained in a specific pathogen-free environment in barrier facilities in Albuquerque,
NM, and conform to the principles outlined by the Animal Welfare Act and the National
Institutes of Health guidelines. Splenocytes from these mice were stimulated with antiCD3 (145-2C11) and anti-CD28 (PV-1) antibodies. Anti-CD3-APC (eBioscience, Cat 170031-83),

anti-CD4-FITC

(eBioscience,

Cat

11-0041-82),

anti-CD8-APC-Cy7

(eBioscience, Cat 47-0081-82), anti-CD197-PE (BD Biosciences, Cat 560682), and antiCD127-PE Cy7 (eBioscience, Cat 25-1271-82) were used for staining T cell populations
from total splenocytes. DND-41 cells (Deutsche Sammlung von Mikroorganismen und
Zellkulturen GmbH, ACC 525) were cultured in RPMI containing 10% fetal bovine serum.
2.5.3. Stimulation of T cells
Splenocytes from C57BL/6 mice were treated with anti-CD3 (0.5 µl mL-1) and anti-CD28
(0.5 µg mL-1) on day 0 (D0). Cells were treated with 20 U mL-1 IL-2 (Teceleukin) on D2,
D4, D6. Resulting T cells were used on D6-D8 for in vitro experiments.
2.5.4. GTP-bound RhoA quantitation
RhoA activation was measured in in vitro activated T cells with a G-LISA kit (BK124,
Cytoskeleton, Inc.). Cells were treated with CCL21 1 µg mL-1, IL-7 10 ng mL-1, IL-7 100
ng mL-1, or untreated for 1-3 minutes prior to cell lysis. Equal numbers of cells in each
group were lysed using kit-provided cell extraction buffer. Lysates were equalized to 25
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µg per well using lysis buffer. Anti-RhoA primary antibody incubation followed by an
HRP-conjugated secondary antibody incubation were performed for detection of GTPbound RhoA. The signal was measured by absorbance at 490 nm.
2.5.5. T cell homing
On days -3 and -1, recipient mice were administered 250 µg anti-IL-7 or isotype antibody
in PBS intraperitoneally. Single cell suspensions from GFP+ murine LNs and spleens were
treated with anti-IL-7R or isotype antibody (10 µg mL-1) for 10 minutes and adoptively
transferred (3.0 x 107 cells) into recipient mice on day 0. After a homing period of 4.5
hours, the recipient mice were sacrificed and peripheral blood, spleen, and LNs were
harvested. Single cell suspensions from the tissues were measured by flow cytometric
analysis.
2.5.6. Flow cytometry
Single cell suspensions from murine LNs and spleens were stained with conjugated
antibodies (listed in Mice and reagents) according to standard immunology protocols. Data
was acquired using a BD LSR Fortessa (BD) and analyzed using FlowJo (FlowJo, LLC).
Flow cytometric analysis of primary murine cells consisted of gating on lymphocytes
population from FSC x SSC, gating on CD3+ or CD19+ events, then gating on GFP+
events. These populations were then assessed for CCR7+ events and IL-7R+ events.
DND-41 cells were rested in serum-free media for 1 hour at 37°C, cells were treated with
either CCL21 (1 µg mL-1), IL-7 (1 µg mL-1), or both CCL21 (1 µg mL-1) and IL-7 (1 µg
mL-1) for 2 minutes prior to fixation with paraformaldehyde. Cells were permeabilized
with BD Phosflow Perm Buffer III (BD Biosciences, Cat 558050) for 30 minutes on ice
and washed with 0.1% saponin in PBS. FITC anti-ERK1/2 Phospho (Thr202/Tyr204)
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Antibody (Biolegend, Cat 369520) was incubated at a ratio of 1:30 in FACS buffer for 1
hr at room temperature. Flow cytometric analysis of cells stained for phosphorylated
proteins consisted of gating on single cells from FSC-H x FSC-A, gating on the
lymphocytes population from FSC x SSC, then gating on pErk1/2+ events.
2.5.7. Two-photon microscope setup
LNs were imaged using two microscope setups. Zeiss LSM510 META/NLO microscope
(25x objective): A Chameleon Ti:Sapphire (Coherent) laser was tuned to either 820 nm for
excitation of CMTMR or 850 nm for simultaneous excitation of YFP and CMTMR or GFP
excitation. ZEN software (Zeiss) was used to acquire time-lapse z-stacks with duration 1545 minutes. Z-step increment: 4 µm. Prairie Technologies Ultima Multiphoton microscope
from Bruker (20x objective): A Ti-Sapphire (Spectra Physics) laser was tuned to either 820
nm for excitation of CMTMR or 850 nm for simultaneous excitation of YFP and CMTMR
or GFP excitation. Prairie View 5.4 software (Prairie Technologies) was used to acquire
time-lapse z-stacks with duration 15-45 minutes. Z-step increment: 4 µm.
2.5.8. Two-photon microscopy of intact LNs
Mice were sacrificed and harvested LNs were transferred to an Chamlide AC-B25 chamber
(Live Cell Instrument) containing oxygen superfused DMEM (Gibco, 21063-045) and
maintained at 5% CO2 and 37°C. During imaging, LNs were stabilized to the coverslip
using slice anchors (Warner Instruments, SHD-42/10 WI 64-1421).
2.5.9. T cell tracking and DC quantitation
T cells were tracked using semi-automated Spots function in Imaris (Bitplane) with manual
correction. Distances to DCs were measured by creating Surfaces of DC channel
fluorescence, performing a distance transformation on tracked Spots with respect to the
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outside of the Surface. For each Spot, the output of the Intensity Center for the distanced
transformed channel is the distance to the outside of the closest Surface. MATLAB
(Mathworks) was used to calculate the percentage of each track within 5 µm of a Surface.
For T cell turning angles close and far to DCs, tracks were split into two groups: tracks
with no coordinates 25 um farther than a DC, and tracks with coordinates 25 um or farther
from a DC. Turning angles (TAs) were computed by finding the magnitude of two vectors,
𝑣1 and 𝑣2 , from 3 coordinates and determining the cosine of the turning angle using the
following equation:

cos(𝑇𝐴) =

̅̅̅.
𝑣
𝑣2
1 ̅̅̅
|𝑣
̅̅̅||𝑣
1 ̅̅̅|
2

2.5.10. T cell track idle time calculation
The fraction of time a T cell track spent constrained was performed using the following
steps. It was assumed that each 2PM movie frame 𝑖 occurs at time 𝑡𝑖 , with time 𝑡𝑐 being
the

constrained

time,

𝑡𝑐 = 𝑡𝑖2 − 𝑡𝑖1
if the distance between the T cell time 𝑡𝑖1 and all time frames between 𝑖1 and 𝑖2 is less than
the specified constrained distance, 5 µm
|𝑥𝑖 − 𝑥𝑖1 | < 5 𝜇𝑚, 𝑖 = 𝑖1 , … 𝑖2.
Time was not counted as time constrained until the time difference 𝑡𝑖2 − 𝑡𝑖1 was greater
than 100 seconds. This was done because even fast-moving T cells remained close to their
initial positions in subsequent frames. Once a T cell exited the 5 µm radius, e.g. at frame
𝑖3 , distances and constrained times were tracked from 𝑥𝑖3 and 𝑡𝑖3 .
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2.5.11. T cell track volume calculations
To calculate the volume covered by each T cell track, microscope fields were divided into
voxels of 2.5 µm3. The distances between each T cell and the centers of its surrounding
voxels were calculated. The volume of the cube was included in the track volume
calculation if the distance between the T cell and the center of the voxel was less than the
radius of the cell. T cells were assumed to have a radius of 5 µm. Voxel volumes were only
counted once per T cell track in the event a T cell traversed the same voxel multiple times.
The calculation-eligible voxel volumes were summed and divided by the total time the T
cell was tracked.
2.5.12. T-DC contacts model
Simulated DCs were assumed to have a radius of 5 µm. Simulated DCs were distributed
uniformly in a 360 x 360 x 360 µm cube and occupied 5% of the total volume. Empirical
T cell tracks were embedded in the cube at the tracks’ field coordinates. 200 different DC
distributions were created for each set of T cell tracks and the results from each distribution
were averaged. A T-DC contact was counted if the distance between a T cell center and a
DC center was less than 10 µm. Unique contacts were defined as a DC being counted only
once for a particular T cell track, and the total contact definition allowed for counting the
DC as many times as a particular T cell track entered the threshold distance (10 µm).
2.5.13. Statistical Analysis
Statistical analysis was done using MATLAB with the specific analyses performed and
exact p-values reported in the individual figures. For flow cytometry data, means are shown
and student’s T test used to test statistical significance. For motility data, we have
previously shown that motility data is non-normal, and thus, require non-parametric tests
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(Letendre et al., 2015). In general, we show medians of motility data and use the Mann
Whitney non-parametric test to test statistical significance of motility data.
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CHAPTER 3: Quantitative Measurement of naïve T cell association with dendritic
cells, FRCs, and blood vessels in lymph nodes
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Abstract: T cells play a vital role in eliminating pathogenic infections. To activate, naïve
T cells search lymph nodes (LNs) for dendritic cells (DCs). Positioning and movement of
T cells in LNs is influenced by chemokines including CCL21 as well as multiple cell types
and structures in the LNs. Previous studies have suggested that T cell positioning facilitates
DC colocalization leading to T:DC interaction. Despite the influence chemical signals,
cells, and structures can have on naïve T cell positioning, relatively few studies have used
quantitative measures to directly compare T cell interactions with key cell types. Here, we
use Pearson correlation coefficient (PCC) and normalized mutual information (NMI) to
quantify the extent to which naïve T cells spatially associate with DCs, fibroblastic
reticular cells (FRCs), and blood vessels in LNs. We measure spatial associations in
physiologically relevant regions. We find that T cells are more spatially associated with
FRCs than with their ultimate targets, DCs. We also investigated the role of a key motility
chemokine receptor, CCR7, on T cell colocalization with DCs. We find that CCR7
deficiency does not decrease naïve T cell association with DCs, in fact, CCR7−/− T cells
show slightly higher DC association compared with wild type T cells. By revealing these
associations, we gain insights into factors that drive T cell localization, potentially
affecting the timing of productive T:DC interactions and T cell activation.
3.1 Introduction
The adaptive immune response depends on T cell interactions with dendritic cells
(DCs) in the paracortex, or T cell zone, of lymph nodes (LNs). The rate at which naïve T
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cells sample DCs determines how fast the immune system can mount a response to
infection (Mirsky et al., 2011). The development of imaging methods such as two-photon
microscopy (2PM) and histocytometry have enabled direct observation of cell locations in
tissues. Many studies showing the relative location of T cells and DCs suggest that they
are both positioned in the LN to maximize the likelihood of T:DC interactions (Brewitz et
al., 2017; Wong and Germain, 2018). Despite advances in the ability to image and observe
T cells in LNs, few studies make direct quantitative comparisons of how closely T cells
associate with multiple other cells types in LNs.
T cells enter the paracortex of the LN from small post-capillary blood vessels
termed high endothelial venules (HEVs). T cells, DCs, and fibroblastic reticular cells
(FRCs) occupy this region along with blood vessels (BVs). T cells move among DCs,
FRCs, and other T cells to interact with DCs presenting antigen. FRCs are stromal cells
that encapsulate a collagen fiber conduit network which allows for transport of lymph fluid
carrying soluble antigen and chemokines (Baekkevold et al., 2001; Gretz et al., 2000;
Palframan et al., 2001; Sixt et al., 2005b). FRCs produce the chemokine CCL21, which has
an established role in naïve T cell homing into the paracortex from blood vessels (von
Andrian and Mackay, 2000; Stein, 2015). FRCs also provide structural support required
for efficient T cell activation (Novkovic et al., 2016). Bajenoff et al. showed the FRC
network is closely associated with naïve T cells moving within the paracortex, suggesting
that FRCs may provide a network on which T cells migrate (Bajénoff et al., 2006).
There are several hypotheses regarding the role of individual cell types in mediating
T:DC interactions. HEVs are the entry points for T cells entering the LN. Girard et al.
suggests that DCs gather near HEVs to maximize their contact rate with incoming T cells
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(Girard et al., 2012). Others have suggested that DCs may congregate at the intersections
of the FRC network, allowing T cells that travel along the edges of the network to
encounter DCs at an increased rate (Donovan and Lythe, 2016; Shimizu et al., 2004; Textor
et al., 2016; Zeng et al., 2012a). Spatial interactions between T cells and blood vessels,
FRCs, and DCs are important if they change how T cells move through the paracortex and
the timing of encounters with antigen-presenting DCs, the key step in T cell activation and
the initiation of the adaptive immune response.
In addition to structural and cellular cues, chemical mediators, including
chemokines, contribute to T cell motion and T:DC contacts in the LN. For example, the
signaling molecule LPA produced by FRCs has been shown to mediate rapid T cell motion
in LNs (Takeda et al., 2016). In addition, C–C chemokine receptor type 7 (CCR7), the
receptor recognizing CCL21, is important for high speed T cell motility in the LN (AspertiBoursin et al., 2007; Letendre et al., 2015). While CCR7 increases T cell movement speed
in LNs, whether CCR7 impacts T:DC contacts has not been investigated.
Understanding the contribution of cellular and structural LN components to T cell
localization requires a quantitative metric that allows direct comparisons of spatial
associations of multiple cell types. Several other groups have reported spatial relationships
between cells and structures using methods such as visual inspection (Girard et al., 2012;
Mempel et al., 2004) and comparison of turning angles of T cell movements with structures
(Bajénoff et al., 2006; Mrass et al., 2017). However, none of these directly compare
associations between multiple cell types or structures with a consistent quantitative metric.
In this study, we use both the Pearson correlation coefficient (PCC) (Adler and
Parmryd, 2010; Barlow et al., 2010) as well as Mutual Information (MI) (Shannon, 1948)
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to compare the spatial association of multiple cell types and structures. PCC measures the
covariance of homologous pixel intensities, and has been often used to determine
colocalization, particularly of fluorescent proteins, in multiple biological systems including
the study of T cells (Dinic et al., 2015; Dunn et al., 2011). PCC and MI can be calculated
without the need to identify individual cell boundaries which can be difficult for 2PM
images.
MI is an application of Shannon entropy (which measures the amount of uncertainty
about the value of a random variable in bits) originally defined to understand limitations
on signal processing and communication (Smith, 2015). MI quantifies the reduction in
uncertainty about one variable when one knows the value of another variable. In analyzing
spatial associations, we measure the reduction in uncertainty about the location of one cell
type given the location of another cell type. MI has been successfully used in other
biomedical image processing applications, particularly in measuring image similarity in Xrays and MRIs for automated image registration (Kim et al., 2003; Pluim et al., 2003;
Studholme et al., 1999; Viola and Wells, 1997). Furthermore, MI and other information
theoretic measures are increasingly recognized as powerful tools for analysis of non-linear
complex systems, including complex biological systems such as the immune system
(Lizier, 2014; Prokopenko et al., 2009). In this article, we use MI to quantify the spatial
association of T cells with other cell types (e.g., DCs or FRCs). We use MI as a measure
of spatial association that is independent of specific types of cells or structures. In addition,
MI is theoretically insensitive to coarse graining (DeDeo et al., 2013). Thus, MI can
measure the amount of spatial dependence of one fluorescent marker on another while
minimizing observational bias. MI, unlike distance measures such as nearest-neighbor
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analysis, is parsimonious, since it does not require extensive image processing to remove
photon noise and determine cell boundaries. Instead, MI can operate on the image directly
without the introduction of thresholds. In preliminary work we used MI to quantify the
association of T cells and DCs and found less correspondence between T cell and DCs than
expected (Fricke, 2017).
However, MI is not comparable across images with different sizes and amounts of
fluorescence. In this study, we use NMI to normalize MI to be between 0 and 1 (Coombs
et al., 1970; Press et al., 2007; Vinh et al., 2009; Witten et al., 2011), which allows
quantitative comparisons of spatial associations between cells fluorescing in one color
channel and another cell type fluorescing in a different color channel across experiments.
Since PCC and NMI are both pixel-based methods that do not correspond to cell sizes, we
create regions within the images that match cellular scales and apply PCC and NMI.
Analyzing regions as well as pixels allows these methods to capture associations at
biologically relevant scales. Both regional PCC and NMI analyses show T cells associate
much less with their ultimate targets, DCs, than with FRCs. Our results also show that
CCR7 does not increase T cell association with DCs.
3.2. Materials and Methods
3.2.1. Mice and Reagents
Experiments were performed with C57BL/6 mice (Jackson Laboratories),
B6.Ubiquitin-GFP mice (Jackson Laboratories), B6.CCR7−/− mice (Jackson Laboratories)
and B6.Cg-Tg(ItgaxVenus)1Mnz/J mice (Jackson Laboratories). Both female and male
mice were used between 8 and 20 weeks of age. Breeding, maintenance, and use of animals
used in this research conform to the principles outlined by the Institutional Animal Care
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and Use Committee (IACUC). The IACUC at the University of New Mexico approved the
protocol for animal studies (protocol number 16-200497-HSC). Anesthesia via ketamine
and xylazine was performed during mouse injections, and euthanasia was administered via
isofluorane overdose followed by cervical dislocation. For blood vessel staining, DyLight
594 labeled Lycopersicon esculentum (tomato) lectin (Vector Laboratories) was used at a
dose of 70 μg per mouse. To isolate naïve T cells, Pan T Cell Isolation Kit II (mouse,
Miltenyi Biotec, 130-095-130) was used according to manufacturer’s instructions. To
fluorescently

label

naïve

T cells,

CellTracker™Orange

(5-(and-6)-(((4-

chloromethyl)benzoyl)amino) tetramethylrhodamine) (CMTMR) Dye (ThermoFisher
Scientific, C2927) was incubated with naïve T cells at a final concentration of 5 μm at 37°C
for 30 min before being washed. Labeled naïve T cells were then immediately adoptively
transferred into recipient mice.
3.2.2. Mouse Procedures
For all images: 107 naive T cells were adoptively transferred into mice 14–16 h
prior to LN harvest for imaging by 2PM. For T:DC images: T cells from naïve wild type
(WT) mice were labeled with orange vital dye CMTMR and adoptively transferred into
naïve CD11c-yellow fluorescent protein (YFP) mice in which all CD11c+ DCs are YFP+.
For T:BV images: T cells from naïve Ubiquitin-green fluorescent protein (GFP) mice were
adoptively transferred into naïve C57Bl/6 recipient mice. DyLight 594-labeled L.
esculentum (tomato) lectin was injected intravenously into the recipient mice 5 min before
harvesting the LNs for imaging. The fluorescent lectin binds to glycoproteins on blood
vessel endothelial cells and emits red fluorescence. For T:FRC images: T cells from naïve
WT mice were labeled with CMTMR and adoptively transferred into Ubiquitin-GFP
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recipient mice that were lethally irradiated (10 Gy). The mice were reconstituted with
C57Bl/6 bone marrow 4 weeks prior to T cell adoptive transfer. In this chimeric mouse
model, the stromal cell populations fluoresce GFP while the hematopoietic cell populations
are non-fluorescent.
3.2.3. Two-Photon Microscopy Setup
Two-photon microscopy was performed using either a ZEISS LSM510
META/NLO microscope or Prairie Technologies UltimaMultiphoton microscope from
Bruker. Prairie Technologies UltimaMultiphoton microscope from Bruker: A Ti-Sapphire
(Spectra Physics) laser was tuned to either 820 nm for excitation of CMTMR or 850 nm
for simultaneous excitation of YFP and CMTMR, GFP and DyLight 594, or GFP and
CMTMR excitation. The Prairie system was equipped with Galvo scanning mirrors and an
801 nm long pass dichroic to split excitatory and emitted fluorescence. Emitted
fluorescence was separated with a 550 nm long-pass dichroic mirror. Fluorescence below
550 nm was split using a 495 nm dichroic and filtered with 460/60 and 525/50 nm filters
before amplification by photomultiplier tubes. Fluorescence above 550 nm was split with
a 640 nm long-pass dichroic mirror before passing through 590/50 and 670/50 nm filters
before amplification by GaAsP photomultiplier tubes. AUMPlanFLN 20× water
immersion objective (0.5 numerical aperture) was used. Prairie View 5.4 software (Prairie
Technologies) was used to acquire time-lapse z-stacks. ZEISS LSM510 META/NLO:
Chameleon Ti:Sapphire laser tuned to 850 nm (Coherent) was used for excitation of either
GFP and CMTMR, YFP and CMTMR, or Dylight 594 and GFP. A 560 nm dichroic mirror
and 500–550 and 575–640 nm band pass filters were used for detection of fluorophores.
Movies were captured with the ZEN user interface (Zeiss). In both imaging systems, z-
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stacks with step size of 4 μm were repeatedly imaged over time to obtain movies of 10–
45 min in duration. All analyses were performed on 2D image z-stacks captured by 2PM.
3.2.4. Lymph Node Preparation for Live Imaging
After euthanasia, LNs from mice were surgically dissected and transferred to a
Chamlide AC-B25 imaging chamber (Live Cell Instruments) with a customized coverslip
platform to allow flow beneath the LN. The LN was stabilized with a tissue slice harp
(Warner Instruments) and superfused with oxygenated Dulbecco’s Modified Eagle’s
Medium (Gibco, 21063-045) and maintained at 37°C. For experiments in which blood
vessels were imaged in conjunction with T cells or DCs, with 70 μg DyLight 594-labeled
lectin (from L. esculentum, Vector Laboratories) was intravenously administered by tail
vein injection 5 min before euthanasia.
3.2.5. Calculation of Mutual Information
MI measures how much the value of one variable tells us about the value of another
variable. In this study, MI is used to quantify how much the locations and color intensities
of DCs, FRCs and blood vessels reveal about the locations and color intensities of T cells.
We calculate the MI of color intensities resulting from 2PM imaging of two cell types.
Each image is composed of a sequence of 2-color 3D images. In these images one cell type
is dyed red and another green. We calculate the MI of the red and green channels from
every image to determine the association of the corresponding cell types for that image.
The 2PM images contain red, blue and green channels. For every time step, we extract the
red and green channels into two separate 3D images r and g. The MI calculation procedure
can be summarized in the following 3 steps:
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1. We calculate the entropy of color intensities in image r and image g: H(r) and
H(g). This measures the uncertainty of the color intensity in each image.
2. We calculate the joint entropy H(r, g) which measures the uncertainty about the
color intensities in corresponding positions in both images.
3. We calculate MI as the sum of the entropies of the individual images H(r) and
H(g) minus the joint entropy of the two images H(r, g). This reveals how much
uncertainty about the color intensity and location of one cell type (i.e., T cells)
is reduced when we know the color intensity and locations of the other cell type.
3.2.5.1. Entropy
Entropy measures the amount of information in the probability distribution of a
random variable (Shannon, 1948). It indicates the uncertainty in the outcome of an event.
Entropy can be understood by considering a coin toss. The probability of heads is 𝑝(𝑥) =
1
2

1

1

1

1

and the probability of tails is 𝑝(𝑦) = 2. The entropy H is − (2 × 𝑙𝑜𝑔2 (2) + 2 ×
1

1

𝑙𝑜𝑔2 (2)). Since 𝑙𝑜𝑔2 (2) = −1, H = 1 bit. The formula for calculating entropy is:
𝐻(𝑟) = − ∑𝑟 𝑝(𝑟) 𝑙𝑜𝑔2 𝑝(𝑟)

(1)

where H(r) is the entropy of variable r and p(r) is the probability of r occurring. Here, we
use log2 so that entropy is measured in bits, the unit of information. The expression is
negated because the log2 of probabilities (which are always less than or equal to 1) is
always negative or 0. Entropy is maximized for a random event in which the probabilities
of all outcomes are equally likely (all N possible outcomes have a probability of occurrence
of 1/N) leading to an entropy of log2(N) bits. Entropy is minimized for a completely
predictable event in which one outcome has a probability of occurrence equal to 1, and all
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other outcomes have 0 probability of occurrence, leading to an entropy of 0. We calculate
the entropy of color intensities in the red and green images. Each image has 256 possible
color intensities for both the red and green images. Thus the maximum H(r) and the
maximum H(g) is log2(256) = 8 bits which would occur if each of 256 color intensities
were equally likely.
3.2.5.2. Joint Entropy
We use joint entropy to measure the uncertainty in the outcome of two variables:
𝐻(𝑟, 𝑔) = − ∑𝑟 ∑𝑔 𝑝(𝑟, 𝑔) 𝑙𝑜𝑔2 𝑝(𝑟, 𝑔),

(2)

where p(r, g) is the joint probability distribution function of r and g.
The two variables may be unrelated. For example, the joint entropy in the outcome
of tossing a fair coin twice is calculated from the probabilities of four possible events
[heads, heads], [heads, tails], [tails, heads], and [tails, tails]. The probability of each event
is 1/4, resulting in a joint entropy of 2 bits. Since the events are independent, the joint
entropy is equal to the sum of the entropies of each individual coin toss.
Alternatively, two variables could be related. In the extreme case, two variables
could be completely correlated so that the value of one variable gives perfect information
about the value of the other variable. For example, if the second coin toss occurred by
picking up the coin and placing it back on the table with the same face up as before, then
the probabilities of events [heads, heads] and [tails, tails] are both 1/2, and the probabilities
of [heads, tails] and [tails, heads] are both 0. The joint entropy is 1, and equal to either of
the individual entropies.
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In our analysis of fluorescent images we are interested in the co-occurrence of red
and green colors. That is, we wish to know whether knowing the color intensity of green
pixels tells us anything about the color intensity of red ones in the same location. We
calculate the probabilities of all possible color intensities (0 –255) in all corresponding
locations of the red and green images. We define the joint probability p(r, g) as the
probability of each pair of color intensities (0–255) occurring in the corresponding location
in the red and green images. There are 256 × 256 = 65,536 possible combinations of color
intensities. We calculate the number of times every intensity combination occurs in
corresponding locations in an image. Then, we divide by the total number of locations in
the images to turn those occurrences into probabilities. These probabilities are entered in
equation (2) to calculate the joint entropy.
The joint entropy is low when color intensities repeatedly co-occur. Note that, joint
entropy can be low when either the same color intensities repeatedly overlap, or when
different color intensities overlap. For example, if red systematically has lower intensity
than green, joint entropy would still be low if a green intensity of, say, 220 was frequently
co-located with a red intensity of 180. Joint entropy only depends on the frequency of pairs
of values co-occurring in the same locations. Joint entropy is high when there is no
association in color intensities between the red and green images. Thus, in Figure 3.2A
where red and green cells are uniformly randomly distributed, there is minimal cooccurrence of the intensities, and therefore all values in the probability table are low and
uniformly distributed. By contrast, when red and green cells co-occur with the same
intensities in the same locations (Figure 3.2C), the probabilities on the diagonal are high
leading to the minimum possible joint entropy. We observe these scenarios in
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Figures 3.2G,I which are the corresponding joint probability tables for Figures 3.2A,C. For
illustration purposes, the 256 color intensity values are binned into 4 color intensities.
3.2.5.3. Mutual Information
MI is calculated from the entropy of each image and the joint entropy of the two
images using equation (3).
𝑀𝐼(𝑟, 𝑔) = 𝐻(𝑟) + 𝐻(𝑔) − 𝐻(𝑟, 𝑔).

(3)

Intuitively, this formula calculates MI by subtracting the joint entropy of r and g
from the total entropy in both r and g, which leaves the overlap in entropy of r and g.
In Figure 3.2, we illustrate how MI is calculated from a set of 3 simulated images.
The first case (Figure 3.2A) shows simulated red and green cells placed uniformly in
random locations. In most cases, red and green do not overlap as shown in Figure 3.2D
(although by random chance, there is some small co-occurrence of red and green cells that
appear yellow). We calculate MI using equation (3). Because there is little or no cooccurrence of red and green pixels in Figure 3.2A, the joint entropy H(r, g) ≈ H(r) + H(g),
so MI ≈ 0.
The second case, in Figure 3.2B, shows red cells placed within in a Gaussian
distributed range of the green cells creating partial co-occurrence of red and green pixels.
We can observe this region in Figure 3.2E (colored in yellow) which is the MI, calculated
by summing the entropy of red and green images independently, and then subtracting the
joint entropy (equation (2)). The process to calculate the joint entropy of the two images is
described in Section 2.5.2 Joint Entropy.
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The third case (Figure 3.2C) is a special case where the red and green pixels are of
same intensity residing in the same location. When separated as two images, red and green
cells completely overlap, shown in Figure 3.2F. In this case, information about the location
of red cells provides all the information about the location of green cells. Because there is
total correspondence between the intensity of red and intensity of green in the same
location, the joint entropy H(r, g) = H(r) = H(g), and the MI therefore equals H(r) (and also
equals H(g)).
3.2.6. Normalized Mutual Information
The MI analysis quantifies in bits the amount information shared by images
showing the locations of two different cell types. However, the number of bits is influenced
by the dimension of images and the numbers and sizes of cells. It does not provide us with
a universal scale with which to compare the association of T cells with other cell types. For
this, we define and calculate NMI as:
𝑀𝐼(𝑟,𝑔)

𝑁𝑀𝐼 = min(𝐻(𝑟),𝐻(𝑔)).

(4)

We normalize MI by the minimum entropy image. MI depends on both the joint
entropy and the internal (marginal) entropies of each color channel. The internal entropies
vary across experiments, resulting in MI values that are not directly comparable. We
normalize by dividing MI by the minimum of the internal entropies, since it provides an
upper bound on MI, for a proof see (Gray, 1990).
The value of NMI is bounded between 0 and 1, where 0 indicates no occurrence of
the red and green cells in the same location as in Figure 3.2A, and 1 indicates complete
colocalization of the red and green cells as shown in Figure 3.2C. NMI allows us to directly
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compare spatial association of cells, regardless of the cell types, cell sizes, and image
dimensions in our experiments.
We validated the NMI metric on simulated data generated as 512 × 512 RGB
images shown in Figure 3.3A. Each cell is a square of 11 × 11 pixels with randomly chosen
color intensities ranging from 0 to 255. In each image, 500 green cells are placed uniformly
at random along with a number of red cells uniformly distributed between 100 and 500.
We placed each red cell within a distance determined by a Gaussian distribution from each
green cell with SDs (σ) ranging from 0 (generating complete correlation of the red and
green pixels) to 10 (generating a low probability of overlap of red and green pixels). We
treat the image as a torus to avoid edge effects when placing red cells. We also analyzed
images in which both green and red cells are placed uniformly at random (u), and therefore
with no spatial association and minimum MI.
NMI is designed to normalize for variations in cell numbers. To assess the potential
effect of cell numbers on NMI, we simulated images in which we varied the cell numbers
from 100 to 500 and calculated NMI for differing cell numbers with complete cell overlap
(σ = 0, increasingly spatially separated σ = 1 or σ = 3 or cells placed in a uniform random
distribution Figure S2 in Supplementary Material). We also calculated PCC as a
comparison. We find that NMI is less sensitive to variations in cell numbers than PCC,
particularly in cases in which there is spatial association.
3.2.7. Regionalization of Images
NMI is calculated from the intensity of pixels in corresponding locations. However,
cells comprise multiple pixels. A naïve T cell has a diameter of approximately 5–7 μm
whereas the approximate length of a pixel is 1.2 μm. Therefore, we created regions in the
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image and call this process “regionalization.” In regionalization, for each pixel (p), we
calculated a region around it with a specified length; for example in a 5 × 5 pixel
(6 μm × 6 μm) region, p is the middle pixel. We replaced the value of p with the average
color intensity of all cells in its region. We iterated over all pixels, discarding the regions
along the image boundaries where complete regions could not be formed. This method
produced new images where each pixel has the average intensity of its region. We
calculated the MI, NMI, and PCC of these regionalized images. We used region sizes: 5 ×
5 pixels (6 μm × 6 μm), 15 × 15 pixels (18 μm × 18 μm), and 25 × 25 pixels
(30 μm × 30 μm). We are most interested in region sizes between 5 × 5 (6 μm × 6 μm) and
15 × 15 pixels (18 μm × 18 μm), since these scales are most relevant to our biological data.
We validated both NMI and PCC for regionalized images. For validation, we used
512 × 512 simulated images that are constructed using the same method mentioned in
Section 2.6 Normalized Mutual Information. Analysis is performed on 500 green cells and
500 red cells. These simulated images are then divided into regions using the
regionalization method. The size of the regions is consistent with the ones we used for
experimental data. Results from NMI and PCC analysis on these images are shown in
Figure 3.4. NMI and PCC decrease with decreasing spatial association, following a trend
similar to that in the validation analysis shown in Figure 3, although region size influences
PCC more than NMI.
3.3. Results
3.3.1. PCC Shows T Cells Associate More With FRCs Than DCs in LN
To ask whether naïve T cells associate with DCs in the LN, we used PCC, a
standard colocalization measure. As a comparison, we also calculated the PCC of T cells
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and FRCs because it has been suggested that T cells use FRCs as a network for migration
through the LN (Bajénoff et al., 2006). We transferred CMTMR-labeled T cells into
CD11c-YFP mice, harvested LNs for 2PM imaging, and calculated PCC of T cells and
DCs from multiple images of T cells and DCs. We imaged FRCs as previously described
by Bajénoff et al. (Bajénoff et al., 2006) by irradiating Ubiquitin-GFP animals,
reconstituting with whole bone marrow from non-GFP animals for 4–8 weeks, and coimaged GFP+ FRCs with co-transferred CMTMR labeled T cells. We find the PCC of
T:DC microscopy images was low (Figure 3.1A) (median = 0.1916, results given to four
significant figures throughout). In fact, the PCC of T cells to DCs was significantly lower
than PCC of T cell with FRCs (T:FRC PCC median = 0.3810). In Figure 3.1, we use
interquartilerange notched box plots to visualize the statistical relationships between
measurements (Mcgill et al., 1978). Non-overlapping notches indicate the measurements
were drawn from different distributions at the 95% confidence level. While previous
studies have determined association of T cells with FRC and DC subsets separately, we
quantitatively compare the effect of FRCs relative to DCs on T cell positioning. These
results suggest that FRCs show much higher correlation with naïve T cell locations in the
T cell zone of LNs than the presumed intended targets of DCs.
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Figure 3.1. Notched boxplots displaying PCC (a) and NMI (B) values for T:DC,
T:FRC, and T:BV images. Data include 6 T:DC image z-stacks (2 experiments on 2
different days, 2 mice, 4 lymph nodes), 12 T:FRC image z-stacks (3 experiments on 3
different days, 6 lymph nodes), 4 T:BV image z-stacks (2 mice on 2 different days, 3 lymph
nodes). Black dots indicate the mean. Median T:DC PCC value = 0.1922, median T:FRCs
PCC value = 0.3810, median T:BV PCC value = 0.2447. Mann–Whitney p values for
T:DC–T:FRCs < e−4, T:DC–T:BV = 0.0293, and T:FRC-T:BV < e−4. Median T:DC NMI
value = 0.0101, median T:FRC NMI value = 0.0798, and median T:BV NMI value =
0.1355. Mann–Whitney p values for T:DC–T:FRC, T:DC–T:BV, and T:FRC-T:BV
comparisons < e−4.

3.3.2. Application and Validation of NMI as a Novel Method to Assess T Cell Association
With Cell Types in LN
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While PCC provides a quantitative metric to assess the correlation among pixels in
images, PCC assumes that these correlations are linear (Adler and Parmryd, 2010; Dunn et
al., 2011; Fletcher et al., 2010; Reshef et al., 2011). We use NMI (a normalized version of
MI) to quantitatively assess spatial relationships between cell types without assuming
linearity. The principles of MI are illustrated using simulated images in Figure 3.2.
We calculated the entropy of fluorescence signals using equation (1) and then
calculated the joint entropy using equation (2) (for detail see Methods). We then calculated
the MI of the signals using equation (3). To validate our MI calculations, we created
simulated images with fields of green and red “cells” in which there is no association
(Figure 3.2A), partial association (Figure 3.2B), and complete association (Figure 3.2C) of
fluorescent objects with sizes similar to that of cells. The 3 cases can be simplified by
observing the images in Figure 3.2D (no association), Figure 3.2E (partial association
marked as yellow area), and Figure 3.2F (complete association marked as yellow area).
The joint probability tables (simplified examples in 4 × 4 color intensities shown in Figures
2G–I) are used to calculate the joint entropy. If there is no spatial association, the joint
probability table shows evenly distributed low values (Figure 3.2G). Given partial spatial
association of cells, the joint probability table shows increased values across the diagonal
(Figure 3.2H). Given completely overlapping signals, the joint probability table shows high
values across the diagonal (Figure 3.2I). Because MI is calculated from fluorescent images
in which different images possess different internal entropies, we normalized the MI values
to provide a universal scale (between 0 and 1) with which to compare one image to another.
We calculated NMI by normalizing MI with the minimum entropy of the two images, thus
enabling quantitative comparisons across fields.
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In Figure 3.3A, we show examples of simulated images created for validating NMI
(described in Section 2.6 Normalized Mutual Information) in which red cells were placed
with SD (σ) of 0 and 5 as well as red cells placed uniformly at random. We expect the MI
and NMI values to decrease as the SD increases, as shown in Figure 3.3B (MI) and Figure
3.3C (NMI). As expected, MI and NMI are maximum in the special case 0* where the
intensity, size and location of the cells are all identical; MI and NMI decrease as the spatial
association between the cells decreases. While the MI can be greater than 1 bit (Figure
3.3B), the NMI metric is normalized to be between 0 and 1 (Figure 3.3C), demonstrating
that NMI can provide comparisons to account for differing levels of fluorescence across
multiple fields on a common scale.
As a further validation, we tested whether NMI calculations on our experimental
data range between 0 and 1. Figure S1 in Supplementary Material shows that the NMI of
an image with itself is 1 (Matched Red:Red and Matched Green:Green). We calculated
NMI of two unrelated images from two different experimental fields (Unmatched
Red:Green). For example, the red cell image may be taken from a T:DC experiment and
the green cell image from a T:FRC experiment. As expected, NMI in these cases is very
close to 0 (Figure S1 in Supplementary Material). We then calculated the NMI of T:DC
and T:FRC interactions using the same images on which we calculated PCC (Figure 3.1B).
We find that similar to PCC analyses, NMI shows significantly higher association for
T:FRC than T:DC (T:FRC NMI median = 0.08; T:DC NMI median = 0.01).
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Figure 3.2. | Illustration of low, medium and high MI. Simulated images of 500 red and
500 green cells are shown in panels (a–c). Each cell is a square of 11 × 11 pixels. The
location and color intensity of each green cell is chosen from a uniform random
distribution. A red cell is paired with each green cell. The red cell has the same color
intensity as the green cell, but with a different spatial association in each case. In panel (A),
red cells are placed at random locations uncorrelated with green cell placements. In panel
(B), the placements of red and green cells are partially correlated. Red cell locations are
chosen from a Gaussian distribution centered at the location of the paired green cell, but
with a standard deviation (σ = 5). In panel (c), the location of red and green cells is identical
(σ = 0). (D–F) Set diagrams indicating the shared information between red and green
channels. In panel (D), the two color channels are independent since cell locations are
uncorrelated with each other providing minimum MI. In panel (e), the two images are
partially correlated which increases the MI, shown by the yellow shaded region. In panel
(F), the two images are completely correlated maximizing the MI of the two color channels,
resulting in complete intersection of the information in the red and green channels (yellow
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region). Panels (G-I) joint probability tables for images (A-C) where 256 color intensities
are binned into 4 color intensities for purposes of illustration, resulting in a 4 × 4 probability
table. In panel (G), the probability values are low and evenly spread across the table, except
for the upper left corner, indicating overlap in the space with no cells (MI = 0.0011 bits).
In panel (H), the probability values are higher along the diagonal than in other parts,
indicating partial correlation in the placement of red and green cells (MI = 0.0320 bits). In
panel (i), there are probability values on the diagonal only and the probabilities off the
diagonal are 0 since there is complete correlation in the placement of red and green cells
(MI = 0.8610 bits). The calculation of entropy H(r) and H(g), joint entropy H(r, g), and MI
are shown for each case.
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Figure 3.3. Validation of MI and NMI. Panel (A) shows 3 samples of simulated 512 ×
512 images that consist of 500 green cells and a number of red cells uniformly distributed
between 100 and 500. Each pixel intensity of the red and green cells is randomly assigned,
and each cell is a square of 11 × 11 pixels. The red cell locations are chosen from a Gaussian
distribution centered at the location of green cells with SD (σ) 0 and 5 in the first and
second images, and uniformly random in the third image. (B) shows boxplots of MI in bits
and (c) shows boxplots of NMI (unitless) of simulated images where the SD (σ) ranges
from 0 to 10. 2 additional special cases are shown: 0* and u. 0* indicates that red and green
color intensities are identical in corresponding locations which maximizes both MI and
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NMI. u indicates that the cells are placed uniformly at random within the image and with
uniform random color intensity, resulting in the lowest MI and NMI. Increasing σ decreases
the spatial association of cells. As spatial association decreases, and both MI and NMI
systematically decrease, demonstrating that they are useful metrics that indicate spatial
association between cells.
3.3.3. Regional PCC and NMI Analyses
We first calculated both PCC and NMI using pixel-based comparisons (Figure 3.1).
We find that PCC and NMI show a significantly higher association of T cells with FRCs
than DCs. However, NMI and PCC pixel-based metrics can be problematic. Intercellular
interactions in 2PM images are challenging to quantify by existing colocalization analyses
because individual cells occupy discrete physical space, but pixel-based colocalization
methods measure the amount of fluorescence signal overlap in individual pixels. In fact,
any actual overlap in cell signal as measured by PCC and NMI is likely artifactual in that
cells do not physically overlap in space. Also, it is possible that true intercellular contacts
would be underestimated due to image resolution and the inability to resolve smaller
protrusions such as dendrites of DCs. To account for cell-cell association rather than actual
signal overlap based on pixels, we regionalized our images using sliding windows of
multiple pixels, the size of which matched approximate sizes of T cells (estimated 5 μm
diameter), DCs (estimated 10–15 μm diameter), and FRCs (estimated 5–7 μm diameter).
The regionalized image has the same number of pixels as the original, but each pixel
contains information drawn from the region surrounding it. Given that each pixel is
approximately 1.2 μm in length, we created regions of 5 × 5 pixels (6 μm × 6 μm) and
15 × 15 pixels (18 μm × 18 μm) to account for potential extensions beyond the cell bodies.
We also extended analysis to larger region sizes. Fluorescence in regions was determined
by taking the average fluorescence of all the pixels within the region (for detail see Section
2.7 Regionalization of Images). We used this method to generate new regionalized images
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and performed both PCC and NMI to take into account potential interactions of cells
without directly overlapping fluorescent signals.
We first tested the “regionalization” effect by performing PCC and NMI on
simulated images (as shown in Figures 3.2A–C and 3.3A) to determine the effect of cell
density, degree of pixel overlap, and regionalization on co-association (Figure 3.4). We
created simulated images that approximate the amount of fluorescence in our experimental
images. We varied the distance between the simulated cells to model different amounts of
spatial association. We applied our regionalization method to these simulated images and
calculated NMI and PCC values. We found that larger regions produce higher NMI and
PCC values. Compared with NMI, PCC is less sensitive to changes in spatial association
but more sensitive to region size (compare Figures 3.4A,B). Despite these differences, both
NMI and PCC provide a quantitative measure that can be used to detect variation in spatial
association among cell types.
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Figure 3.4. Regionalized PCC and NMI on simulated data. Simulated images are 512
× 512 pixels with 500 red and 500 green 11 × 11 pixel square-shaped cells. The red cell
locations are chosen from a Gaussian distribution centered at the location of green cells
with SD (σ), which ranges from 0 to 10 and u. u indicates that the cells are placed uniformly
at random within the images and with uniform random color intensity. (A) NMI calculated
on simulated images with regions of sizes 6 μm × 6 μm (blue), 18 μm × 18 μm (green), 30
μm × 30 μm (red), and single pixels (1.2 μm × 1.2 μm, cyan). (B) PCC of simulated images
using the same regions.
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3.4. Regional Analyses Confirm That T Cells Are More Associated With FRCs Than With
DCs
After validating both the NMI metric and the regionalization of images, we
analyzed regionalized images to quantify spatial association of T cells with DCs and FRCs
using both PCC and NMI (for sample images see Figure 3.5A). Both PCC and NMI show
that T cells associate less with DCs than FRCs (Figure 3.5B for NMI and Figure 3.5C for
PCC). T cells are more associated with FRCs across all region sizes. In pixel-based
comparisons (without regionalizing), the T:DC association was very low (Table 1,
NMI = 0.0101; PCC = 0.1916) while T:FRC association was significantly higher (NMI =
0.0798; PCC = 0.3810). Both NMI and PCC values for T:DC interactions increased with
increasing region sizes, T:FRC association also increased at each region size.
Regionalizing PCC into 18 μm × 18 μm region (15 × 15 pixels) resulted in the same trend
among the compared cell types as NMI (Figure 3.5B NMI; T:DC median = 0.1427, T:FRC
median = 0.3426; Figure 3.5C PCC T:DC median = 0.4396, T:FRC median = 0.7646,
Table 1). Figures 3.5D,E compare physiologically relevant regions that approximate cell
sizes and account for potential dendritic extensions with larger regions for DCs at 18 and
30 μm than FRCs at 6 μm. Again, T:FRC associations are greater than T:DC associations
using both NMI and PCC. Thus, across region sizes, both NMI and PCC analyses show
significantly higher T cell association with FRCs compared with DCs. These results
suggest that despite the fact that DCs are considered the ultimate targets for T cell search,
FRCs a greater determinant of naïve T cell positioning within the LN.
In addition to FRCs and DCs, structures such as blood vessels in the LN can be
sources of chemokines (Gretz et al., 2000; Stein et al., 2000), and T cells may move along

83

vessels in other tissues (Mrass et al., 2017). Several studies suggest DCs are biased to
localize near blood vessels and efficiently activate antigen-specific T cells (Bajénoff et al.,
2003; Mempel et al., 2004). We used NMI and PCC to ask whether vasculature can
determine T cell localization in LN. We transferred GFP+ T cells for 16 h as previously
described, then just prior to imaging, we injected animals with DyLight 594-lectin which
binds endothelial cells lining blood vessels. We then imaged T cells in conjunction with
vasculature in LNs. With the pixel-based PCC (Figure 3.1A) and NMI analyses (Figure
3.1B), T cell association with blood vessels appears higher than T cell association with
DCs, and NMI shows higher T cell association with blood vessels than even FRCs.
However, with increasing region size, PCC and NMI analyses of T:BV values stayed
consistent while T:DC values increased, for example, in the 18 μm length region, NMI of
T:DC was 0.1427 and T:BV was 0.1036. The same trend was seen for PCC
(T:DC = 0.4396, T:BV = 0.2603). The consistent value of NMI and PCC analyses of T:BV
across regions likely reflects the sharp resolution of the blood vessel fluorescence
compared with the more blurred extensions of FRCs and DCs. With increasing region size
matching cellular scales, T cells show lower association with BVs (Figures 5B,C). These
results suggest that T cells likely do not use crawling along vessels as a means to migrate
within T cell zones of LNs.
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Figure 3.5. RNMI and PCC of cell types within lymph node. (A) Sample images of
T:DC (T cells labeled in red and DCs labeled in green), T:FRC (T cells labeled in red and
FRCs labeled in green), and T:BV (T cells labeled in green and blood vessel labeled in
red). (B,C) Line plots representing the NMI (B) and PCC (D) of T cells and DCs (T:DC,
green line), T cells and FRCs (T:FRC, blue dashed line), and T cells and blood vessel
(T:BV, black dotted line). NMI and PCC were calculated on pixels (region length = 1.2
μm), or regionalized images of increasing side length (6, 18, and 30 μm). Red stars indicate
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medians for the corresponding region size, and error bars indicate the 95% confidence
interval around the median (40). For NMI, Mann–Whitney p values for T:DC–T:FRC,
T:DC–T:BV, and T:FRC-T:BV comparisons < e−4 for all region lengths except T:DC–
T:BV (region length = 18 μm) p value = 0.0012. For PCC, Mann–Whitney p values for
T:DC–T:FRC, T:DC–T:BV, and T:FRC-T:BV comparisons < e−4 for all region lengths
except T:DC–T:BV (region length = 1.2 μm) p value = 0.0293. (D,E) Notched box plots
comparing the NMI (D) and PCC (E) of T cells and DCs with T cells and FRCs at
physiologically relevant region lengths of (6, 18, and 30 μm) for T:DC associations and 6
μm for T:FRC associations. Note different scales on the y-axis. Both NMI and PCC are
greater for the physiologically relevant region sizes for T:FRC than for T:DC (comparing
T:DC at 30 μm to T:FRC at 6 μm p = 0.0022; for all other comparisons p < e–4). T:DC
images were from 6 image z-stacks consisting of 4,089 frames from 2 mice and 4 lymph
nodes. T:FRC images were from 12 image z-stacks consisting of 9,468 frames from 3 mice
and 6 lymph nodes. T:BV images were from 4 image z-stacks consisting of 4,361 frames
from 2 mice and 3 lymph nodes.
3.3.5. CCR7 Does Not Enhance T:DC Association
The chemokine CCL21 plays an important role in driving rapid motility of naïve
T cells in LNs, and this rapid motility has been suggested to enhance T cell interactions
with DCs (Wong and Germain, 2018). We tested whether signaling through CCR7 might
provide information to T cells to enable closer T:DC associations. To do this, we
transferred CMTMR-labeled CCR7−/− T cells into CD11c-YFP mice, harvested LNs for
2PM imaging, and calculated NMI and PCC of CCR7−/− T cells and DCs (Figure 3.6A).
Contrary to our hypothesis, we found that in general, CCR7−/− T cells and DCs showed
slightly higher NMI and PCC than WT T:DCs (Figure 3.6B, NMI WT: 0.0101; CCR7−/−:
0.0158 and Table 1). WT T cells showed higher co-association with DCs compared with
CCR7−/− T cells in only one case, pixel-based PCC analysis, while with increasing region
size and in all NMI analyses, CCR7−/− T cells were slightly increased in DC association
over WT T cells (Figures 3.6B,C; Table 1). Based on both NMI and PCC analyses, these
data show that CCR7 does not promote increased T cell localization with DCs. Absence of
CCR7 did not increase T:DC association to the level of T:FRC, as NMI and PCC values of
T:FRC remained significantly higher than CCR7−/− T:DC association. These results
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suggest that high speed motility promoted by CCR7 signaling likely functions to promote
T cell exploration of the LN paracortex rather than increase T cell localization close to
DCs.

Table 3.1. Median NMI and PCC values among cell types with 95% confidence
interval.
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Figure 3.6. CCR7-deficiency does not decrease association of T cells with DCs. (a)
Sample images of WT T:DC and CCR7−/− T:DC. T cells are labeled in red and DCs are
labeled in green. In WT T:DC, T cells are wild-type naïve T cells and in CCR7−/− T:DC,
T cells are from CCR7-deficient animals. (B,c) Line plots representing the NMI (B) and
PCC (c) of WT T cells and DCs (T(WT):DC, green line) and CCR7−/− T cells and DCs
(T(CCR7−/−):DC, blue dashed line). NMI and PCC were calculated on pixels (region
length = 1.2 μm), or regionalized images of increasing side length (6, 18, and 30 μm). Red
stars indicate medians for the corresponding region size, and error bars indicate the 95%
confidence interval around the median (40). For NMI, Mann–Whitney p values for
T(WT):DC–T(CCR7−/−):DC comparisons < e−4 for all region lengths. For PCC Mann–
Whitney p values for T(WT):DC–T(CCR7−/−):DC comparisons for region lengths 1.2, 6,
18, and 30 μm: Region length 1.2 μm p < e−4, 6 μm p = 0.9152, 18 μm p = 0.0021, 30 μm
p < e−4. WT T:DC images were from 6 image z-stacks consisting of 4,089 frames using 2
mice and 4 lymph nodes. CCR7−/− data are from 12 image z-stacks consisting of 11,294
frames using 4 mice and 8 lymph nodes.
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Discussion
In this work, we analyze 2PM z-stacks to quantitatively compare T cell association
with different cell types and structures in the naïve lymph node using both PCC and NMI.
To account for the limitations of 2PM to resolve cell structures, we create regions that
correspond to physiologically relevant cell sizes. Both PCC and NMI across multiple
region sizes show that T cells share more spatial association with FRCs than with DCs.
Furthermore, CCR7−/− T cells do not associate less with DCs than WT T cells; in fact, our
results suggest that CCR7−/− T cells may associate slightly more with DCs than WT
T cells.
Many studies have investigated T cell search for DCs in the naïve LN since DCs
are the key cell type that is required to present cognate antigen to T cells leading to the
initiation of the adaptive immune response (Krummel et al., 2016; Wong and Germain,
2018). Westermann et al. suggest that cell positioning within the LN maximizes the
likelihood of T cell interaction with DCs (Westermann et al., 2005). Other studies
hypothesize that DCs are situated atop the FRC network to facilitate T cell interactions
with DCs as the T cells move along the FRCs (Gasteiger et al., 2016) and that T cells enter
the paracortex from HEVs at specific entry points contiguous with the FRCs network,
enabling T cells to be “received” by a greeting line of DCs positioned on top of the FRCs
near the HEV entry points (Lindquist et al., 2004). Furthermore, different subpopulations
of DCs have been shown to localize to specific regions in the LN, suggesting that DC
positioning relative to T cells may facilitate T cell activation (Gerner et al., 2015).
However, our quantitative analysis using NMI and PCC suggest that T cell association with
FRCs does not necessarily lead to similarly high association with DCs. The lack of
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association between T cells and DCs suggests that T cells have no a priori knowledge of
DC positions and that DCs are unlikely to attract T cells to DC locations prior to infection.
While there is evidence that upon DC activation and infection, chemokines are important
to mediate T cell repositioning to DCs (Castellino et al., 2006; Groom et al., 2012; Lian
and Luster, 2015), our data suggests that chemokines CCL19/21 that bind to CCR7 do not
play a role in T cell positioning to DCs in the absence of infection. We previously
demonstrated that T cells move with a lognormal correlated random walk (Fricke et al.,
2016), which aligns with several other studies in the LN (Banigan et al., 2015; Miller et
al., 2003). Our results suggest that random movement, rather than guided movement, may
be the strategy that naive T cells use to interact with DCs prior to infection.
Although T cells and DCs have low NMI and PCC, we find that unexpectedly, lack
of CCR7 does not decrease association between T cells and DCs, in fact, CCR7-deficient
T cells show slightly increased association with DCs. CCR7 mediates high speed motility
in LNs (Katakai and Kinashi, 2016). One possible explanation for our finding is that CCR7
deficiency in T cells results in slower T cells that cannot efficiently move away from DCs
once they have made contact. Alternatively, CCR7 signaling might be important for T cells
to move along FRCs where they receive chemokinetic and survival signals, including both
CCL21 and other cytokines such as IL-7 so that in the absence of CCR7, T cells stay closer
to DCs, which are not the primary source of CCL21 (Katakai et al., 2008; Link et al., 2007).
While it is known that CCR7-deficient T cells are less capable of activation, our
quantitative analysis suggests that this may not be due to lack of T:DC contacts but rather
may be due to CCR7 effects on overall motility or effects on cosignaling with T cell
receptors.
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We validated both NMI and PCC on simulated data where we directly manipulated
the spatial association of cells and showed that both metrics decrease as spatial association
decreases and as region size increases (Figure 3.4). We designed NMI to normalize for
differences in fluorescence between fields, and NMI can quantify non-linear relationships
between variables (Smith, 2015) while PCC is based on correlation coefficients (Adler and
Parmryd, 2010; Dunn et al., 2011). In addition, information based measures are
theoretically insensitive to coarse graining (DeDeo et al., 2013). Our regional NMI
analyses in both simulated and experimental images is consistent with this theoretical
prediction in that NMI is less sensitive to region size than PCC (Figures 4 and 5). We find
that NMI is also less sensitive to variations in cell number than PCC, particularly in cases
in which there is already spatial association (Figure S2 in Supplementary Material).
Furthermore, NMI based on regions avoids problems associated with pixel-distance
measures that arise from 2PM images containing transient single pixel noise (Pawley,
2013). Cell-distance measures are also problematic because they require the boundaries of
cells, or their centroids, to be well defined. That is usually not the case in 2PM images,
especially in the case of DCs and FRCs.
While both NMI and PCC consistently show that T cells are more spatially
associated with FRCs than with DCs, we note several caveats in interpreting these results.
We considered that T cells may share the highest NMI or PCC with the most numerous
cells or structures that occupy the most volume in the paracortex, simply because they
cannot move away from the abundant cell type or structure without encountering another
cell or structure of the same kind. However, our simulations (Figure 3.3C) validated that
NMI is insensitive to variation in cell number, with fivefold variation in cell number
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causing much less effect on NMI than changes in spatial association. While the amount of
background noise (low-level fluorescence of individual pixels) has some effect on NMI
and PCC, that effect does not change the conclusion that NMI and PCC both indicate higher
spatial association of T cells with FRCs than with DCs.
Similar to previous studies, our experimental method uses irradiation to image
FRCs showing residual GFP+ hematopoeitic cells (between 5 and 10%). Thus, it is possible
that T:DC can contribute to the T:FRC NMI and PCC. However, because NMI and PCC
of T cells with DCs are significantly lower, it is unlikely that the increase in T cell
association seen with FRCs is due to residual DC signal. There may also be limitations in
the use of two photon imaging as the primary mode of visualizing T cell interactions in the
T cell zone as the T cell zone is usually deeper in the LN cortex. Thus, although many
publications have used two photon imaging to understand T cell motion in LNs, T cell
associations with FRCs and DCs may vary depending on the specific areas that are imaged.
In addition, it is possible that staining specific subsets of T cells or DCs may reveal more
or less spatial association than we see with total T cells and all CD11c+ cells.
In summary, our results show that NMI and PCC both provide quantitative methods
to analyze the relationship between two sets of objects, validated in simulations. NMI and
PCC show significant differences for different cell populations labeled with two different
fluorescent markers, providing quantitative comparisons of fluorescent microscopy images
across multiple fields (Strehl and Ghosh, 2003). Thus, both NMI and PCC of
physiologically relevant regions are useful tools to quantify the relationship between
fluorescent cell types. Since MI is a general method for measuring colocalization of
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fluorescence microscopy images including 2PM signals, the NMI and regional analyses
may be broadly applied to any colocalization study of differentially fluorescent objects.
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CHAPTER 4: Discussion
4.1. Overview and significance
Mature naïve T cells circulate throughout the body and home into secondary
lymphoid organs to encounter DCs presenting antigen. In the LN, T cells move to scan
the surface of DCs for cognate pMHC and can become activated following productive
signaling through the TCR in the presence of costimulation. Upon activation in the lymph
node, effector T cells migrate out of the lymph node and traffic to the peripheral tissues
where the antigen was recognized by the immune system. T cell migration is directional
and allows T cells to move from the thymus into the circulation, and from the circulation
into the lymph node, and from the lymph node into the periphery. Migration is regulated
by chemokine receptors and integrin expression on both the T cells and the tissue into
which the T cell is migrating. Coordinated expression patterns enable T cells to resist
shear stress of the circulation, slowly roll, and move against blood flow into tissues.
Within tissues, the movement of T cells is described as motility, as it is observed as a
random walk (Petrie et al., 2009). While chemokines and integrins influence T cell
motility within tissues, it is less clear if this is due to yet imperceivable gradients of
chemokine, or whether chemokines not only induce directional migration, but
chemokinesis (i.e. the ability to induce motion with no directional bias). Motility of naïve
T cells in the lymph node is important for activation, as T cells that do not move around
would not access as many cells presenting antigen, and antigen in the lymph node may be
a rare target for a naïve T cell. Thereby the relationship between a naïve T cell and time
to activation is contingent on the T cell moving to sample the sessile DCs in the
paracortex.
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Many groups have observed that IL-7 can potentiate T cell proliferation in vivo,
but how this occurs has been a mystery. IL-7 signals through IL-7Rα chain and the
common gamma chain to Jak1 and Jak3. PI3K is also activated, which is important for
IL-7-dependent effects of T cell proliferation (Barata et al., 2004). IL-7R signaling can
augment T cell proliferation following TCR stimulation through downregulation of
p27kip1, a cyclin-dependent kinase inhibitor (Li et al., 2006), but in some systems IL-7R
signaling is not required for productive TCR signaling in vitro (Saini et al., 2009). The
mechanisms by which IL-7R signaling promotes T cell responses remains unclear.
We provide a mechanism for IL-7 promoting T cell responses by demonstrating
that IL-7 can induce T cell motility in the LN and that this results in increased DC
scanning. Without IL-7/IL-7R signaling, T:DC interactions can still be productive (i.e.
there is no defect in TCR signaling), but T cells contact fewer DCs per unit time (Figure
2.6) and a slower and smaller response is reported (Saini et al., 2009). While multiple
groups have reported that IL-7 promotes robust T cell responses (Saini et al., 2009; Sun
et al., 2006), it has also been reported that, in some model systems, IL-7 does not have an
effect on in vivo priming of naïve cells, just memory T cell formation (Schluns et al.,
2000). It is possible that these studies have high antigen doses and that the requirement
for T cell scanning of many DCs is less because antigen is presented on a large
proportion of DCs and is therefore abundant. Another possibility is that the IL-7R
downstream signaling pathway, or the signal strength through the signaling pathway,
varies among the studies. An alternative IL-7R signaling pathway was recently
discovered in which NFATc, a transcription factor, is activated in thymocytes by a Jak3dependent mechanism, but independently of STAT5 activation (Patra et al., 2013).
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NFATc in the nucleus results in hypersensitivity to TCR stimulation (Pan et al., 2007).
Nuclear NFATc translocation is at least partially determined by the strength of calcium
flux inducing calcineurin-dependent dephosphorylation of cytosolic NFAT following
TCR signaling (Vaeth and Feske, 2018). IL-7R signaling contributes to NFATc nuclear
translocation independently of calcineurin activity (Patra et al., 2013), thus IL-7R
signaling at the immune synapse may tune the activation threshold for naïve T cells. The
effect of IL-7 could be especially different between systems with low versus high antigen
affinity, where low affinity antigen could result in weaker calcineurin-dependent
response and less nuclear NFATc compared to high affinity antigens. In systems with
strong calcineurin-dependent NFATc activation, there may be no additional effect of IL7-mediated NFATc activation due to maximized NFATc activation.
The significance of this work is in finding a novel function of an established
cytokine, IL-7. We show IL-7 promotes T cell motility and DC scanning, and the
implications are important because most primary T cell responses are initiated by T cells
encountering DCs in the LN and becoming activated. IL-7 could also promote DC
scanning in tertiary lymphoid structures (such as Peyer’s patches), and this would be
valuable to explore given that many tertiary lymphoid structures have alternative sources
of IL-7 (e.g. lymphoid tissue inducer cells, or lymphatic endothelial cells) (Jones et al.,
2016; Nayar et al., 2016) and tertiary lymphoid structures have been shown to be critical
for antigen presentation in peripheral tissues in infection and cancer (Engelhard et al.,
2018; GeurtsvanKessel et al., 2009). IL-7 administration in vivo results in T cell
accumulation and/or activation at peripheral sites in non-human primates (Beq et al.,
2009; Cimbro et al., 2012). IL-7 treatment is safe in humans and is being investigated as
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a therapeutic in HIV to promote CD4+ T cell numbers and in cancer as an adjuvant to
current treatments (Francois et al., 2018; Morre and Beq, 2012; Rosenberg et al., 2006;
Sportès et al., 2008, 2010; Thiébaut et al., 2016). The full mechanism driving T cell
responses following IL-7 treatment is undetermined, but T cell motility may contribute to
these effects. A more in depth understanding of all the in vivo functions of IL-7 may
impact the clinical use of IL-7.

4.2. Crosstalk between IL-7 and CCR7
4.2.1. GPCR signaling requires JAK/STAT signaling
We investigated the downstream signaling of IL-7R leading to motility (Figures
2.3 and 2.4). We found that naïve T cells in anti-IL-7 and anti-IL-7R treated LNs
exhibited reduced motility (Figure 2.2). Blocking the JAK/STAT pathway with
pharmacologic inhibitors in the LN resulted in slower naïve T cell motility (Figure 2.3),
consistent with what was observed with IL-7 and IL-7R antibody blockade. CCR7 is
known to also regulate T cell motility involving pathways including Gαi-associated
GPCR signaling and JAK/STAT (Asperti-Boursin et al., 2007; Soldevila and García‐
Zepeda, 2007; Yu et al., 2008). We find in our studies that IL-7 and CCR7 activate a
similar signaling pathway in that there is reduced motility when either CCR7 or IL-7R
are blocked, but that blocking both does not result in more inhibition than either CCR7 or
IL-7R blockade. IL-7R is primarily known to signal through JAK/STAT pathway, while
CCR7 signals through canonical Gai-associated GPCR signaling leading to activation of
GPCR kinases (GRKs) and β-arrestin (Hauser and Legler, 2016; Zidar et al., 2009).
Cytokines canonically signal through the JAK/STAT pathway, and IL-7R specifically
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signals via JAK1 and JAK3 to STAT5. It has previously been shown that Jak3-/- mice
have impaired migration to LNs in addition to impaired chemotaxis (Soldevila et al.,
2004). Additionally, Jak3-/- DCs have a defect in migration toward CCR7 ligands (RivasCaicedo et al., 2009). Soriano et al. has demonstrated that activation of GPCRs (such as
chemokine receptors) also requires JAK/STAT activation, suggesting that GPCRs may
crosstalk with IL-7R (Soriano et al., 2003). In our studies, JAK inhibition resulted in
reduced naïve T cell motility and STAT inhibition resulted in a dramatic motility defect.
Interestingly, CCR7-/- T cells can still transduce IL-7R signaling to STAT5
phosphorylation normally (Jung et al., 2016), suggesting that STAT5-mediated motility is
independent of CCR7-mediated motility. Therefore, we expect IL-7R-mediated motility
is not secondary to CCR7-mediated motility, although there may be crosstalk in IL-7R
and CCR7 signaling.
Other instances of crosstalk between cytokine signaling and GPCR signaling have
been reported. For example, chemotactic response to RANTES and MCP-1 is dependent
on IL-2R signaling in memory T cells (Loetscher et al., 1996). Antibody blockade of IL12 in mice infected with malaria results in severely impaired chemotaxis to CCR5 ligands
in vitro with a moderate downregulation of CCR5 expression, suggesting IL-12R
signaling may crosstalk with CCR5 signaling (Findlay et al., 2013). While still few
cytokine receptors have been shown to modulate G protein activation, many chemokine
GPCRs have been shown to activate the JAK/STAT pathway. CXCR4 and CCR2 require
JAK2 (Ferrand et al., 2005; Shahrara et al., 2003; Soriano et al., 2003; Vila-Coro et al.,
1999), and JAK1 associates with CCR1 and CCR5 (Shahrara et al., 2003). Our results
indicate that IL-7R and CCR7 signal through the same pathway to naïve T cell motility in
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the LN, and we hypothesize that IL-7R signaling may modulate CCR7 signaling through
JAK1 association. In addition to IL-7R regulation of CCR7 signaling, we also show IL7R alters CCR7 expression at the membrane.
4.2.2. IL-7R modulates surface expression of CCR7
We find IL-7/IL-7R blockade downregulates surface expression of CCR7. This is
a possible mechanism by which IL-7 mediates T cell motility, though the timing of antiIL-7 and anti-IL-7R leading to slower motility (~20-40 minutes) suggests that IL-7
directly promotes motility. IL-7R blockade-induced internalization of CCR7 and not
transcriptional or translational regulation of CCR7 might affect motility via CCR7
downregulation on this time scale. It is likely that the IL-7/IL-7R antibody blockade
results in internalization of the IL-7 receptor, which is evidenced by lower expression of
IL-7R on T cells harvested from lymph nodes following antibody blockade (Figure 2.1E).
IL-7/IL-7R blockade in the LN may be stimulating programs associated with T cell
activation, but these effects may be truly due to lack of signaling through IL-7R which is
downregulated after TCR stimulation. Following TCR stimulation, CCR7 is
downregulated and integrin activation resulting in slower motility occurs. These could be
effects of IL-7R downregulation rather than signaling through the TCR. If CCR7 is
localized at the same membrane domain as IL-7R, then internalization of IL-7R could
also include internalization of CCR7, downregulating it at the same timescale as IL-7R.
Alternatively, downregulation of IL-7R at the membrane could result in signaling to
downregulate CCR7. Discussed below are a few candidates for intermediaries of CCR7
and IL-7R signaling.
4.2.2.1. IL-7-induced SOCS1 expression might regulate CCR7
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Suppressor of cytokine signaling 1 (SOCS1) is induced by cytokine receptor
signaling and negatively regulates numerous cytokines including IL-2, IFNɣ, IL-12, IL15, and IL-7. SOCS1 specifically inhibits JAK1 and JAK2, either by targeting the JAKs
for ubiquitination and degradation or by preventing transphosphorylation through binding
to the JAK SH2 domains (Fujimoto and Naka, 2010; Liau et al., 2018). Because GPCR
signaling can also activate the JAK/STAT pathway, GPCR signaling can also be
modulated through SOCS1. Interestingly, SOCS1 activity results in upregulation of
CCR7 (Yu et al., 2008), whereas it can negatively regulate expression of chemokines
CXCR3 and CCR6 (Yu et al., 2015). Consistent with in vivo regulation of CCR7
expression and lymphocyte migration by SOCS1, forced overexpression of SOCS1 in T
cells up-regulates CCR7 expression and enhances chemotaxis toward CCL19 or
CCL21. (Yu et al., 2008) IL-7R signaling induces SOCS1 via JAK/STAT (Ghazawi et
al., 2016) and SOCS1 targets IL-7R for ubiquitination and degradation (i.e. a negative
feedback loop). It is unclear whether IL-7 regulates downregulation of CCR7 through
SOCS1. A possible mechanism might be that IL-7/IL-7R blockade reduces SOCS1,
which then reduces CCR7 expression.
4.2.2.2. Foxo1 as a common regulator between IL-7R and CCR7
IL-7R and CCR7 share transcription factors that regulate their expression
including Foxo1. Foxo1 promotes IL-7R expression by directly binding to the Cd127
gene (the α chain of IL-7R). When IL-7 signals through IL-7R, activated Akt
phosphorylates Foxo1, which results in downregulation of IL-7R. Deletion of Foxo1
results in reduced T cell numbers and low expression of IL-7R (Carrette and Surh, 2012;
Kerdiles et al., 2009). Foxo1-deficient naïve T cells do not phosphorylate STAT5 and
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have reduced Bcl-2 expression in response to IL-7 treatment (Ouyang et al., 2009). Low
CCR7 expression is also associated with Foxo1-deficiency in naïve T cells, and these
cells have impaired homing to the LN (Kerdiles et al., 2009). Our findings suggest that
Foxo1 may cross-regulate CCR7 and IL-7R which can both lead to decreased T cell
movement within LNs. Whether Foxo1 might also have a role in IL-7R-mediated
regulation of CCR7 is not known, but it is possible that Foxo1 acts as a signal transducer
in addition to its role as a transcription factor (similar to the action of STAT proteins).
4.3. Motility-inducing effect of IL-7 may depend on absence of antigen
IL-7R signaling may promote motility depending on the presence of antigen. IL-7
is in limiting amounts for T cells in the paracortex, but T cells need it for growth and
survival. IL-7R signaling results in downregulation of IL-7R, and this occurs when there
is significant IL-7R signaling at the immunologic synapse upon TCR signaling. Motility
is slow upon the formation of an immunologic synapse which allows for scanning of the
APC, and eventually there is a stop signal transmitted to the T cell if it undergoes
activation by detecting cognate antigen. IL-7R remains downregulated on activated T
cells. One potential mechanism by which IL-7R signaling promotes motility is that as the
naive T cell is scavenging small amounts of IL-7 to sustain survival and metabolism, IL7R levels may remain constant. However, a bolus of IL-7 can result in substantial IL-7R
downregulation and (possibly subsequent CCR7 downregulation) and this decreased IL7R level leads to a drop in motility. In support of this hypothesis is a study by Cinalli et
al. which found that IL-7-starved T cells migrated more in response to chemokines, and
that adding IL-7 plus TCR stimulation inhibited the chemokine-mediated migration
(Cinalli et al., 2005). The authors of this study also proposed that CCR7 signaling allows
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T cells to move to trophic signal-rich regions, but that the trophic signals supplied then
autodownregulate IL-7R receptor expression. We propose that IL-7 promotes motility to
a similar extent as CCR7 ligands in the absence of a productive TCR:pMHC reaction.
Also, others have found that IL-7Rhi memory T cells migrated more upon chemokine
stimulation than IL-7Rlo T cells (Jung et al., 2010). IL-7R signaling may fine-tune the T
cell response to chemokines or directly promote motility with a limited IL-7 dose.
4.4. Limitations of studies on IL-7 in naïve LN
4.4.1. Technical discussion
One technical limitation of this study is the explant model of the LN for 2PM. In
this system, there is no circulation of blood or lymphatics and it is possible these vessels
play a role in intranodal motility. If vessel function is one of providing nutrients or
stimuli in a constant flow through the LN, then that aspect is lacking in our system.
However, the structure of these vessels is still present in the event that T cells use them
for contact guidance in the paracortex. Additionally, because the explant model does not
include internal oxygen regulation, the oxygen within the imaging chamber is at
saturating levels in the perfusion media. Caldwell et al. quantified the in vivo oxygen
concentration in the lymphoid organs and determined the oxygen tension to be relatively
hypoxic (0.5-4.0% oxygen). Additionally, the hypoxic condition was found to favor
differentiation of cytotoxic T cells and LFA-1 expression (Caldwell et al., 2001). In our
system, oxygen is bubbled into the perfusion media which is standard with other lymph
node studies (Benechet et al., 2014; Cahalan et al., 2003; Miller et al., 2002).
Additionally, the flow of the perfused media is maintained at 2 mL min-1 through the
imaging chamber, and this is important for high speed motility of T cells in the lymph
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node as fluctuations in flow result in wide variation in motility. Integrin-mediated
motility of T cells requires shear flow, but it has been reported that intranodal motility
can be integrin-independent (Woolf et al., 2007). Others have reported that adhesiondependent motility is critical for T cell motility along DC bodies (Katakai et al., 2013).
Whether the motility we are observing is due to integrin activation is undetermined.
Despite these abstractions from the true physiology of the LN, we regard the LN explant
system to be representative of the murine LN and congruent with what is reported in
intravital studies of the mouse lymph node (Bousso and Robey, 2004; Germain et al.,
2005).
4.4.2. Potential effect of blocking IL-7 on DCs and stroma
In our studies of IL-7/IL-7R blockade in the LN, the antibodies are added to the
media perfusing the lymph node and the effect is not targeted directly to naïve T cells.
Thus, it is likely that there is an effect on DCs and stromal cells in the paracortex as well.
Though DCs do not express IL-7R, they do express the thymic stromal lymphopoietin
(TSLP) receptor, which is comprised of the IL-7Rα chain and the gamma chain
associated with the TSLP receptor (TSLPR). TSLP is thought to be partially redundant
with IL-7 in thymic development, as IL-7-deficient T cell development can be rescued
with TSLP expression, but IL-7R-deficient T cells are doomed (Chappaz and Finke,
2010). TSLP has not been directly investigated as a regulator of T cell motility (as mature
naïve T cells do not express TSLPR), but it is possible that the blockade of TSLPR on
DCs or stromal cells affects T cell motility via altering production of chemokines or IL-7.
To this end, in vitro TSLP treatment of DCs has been shown to upregulate chemokines
CCL17 and CCL22 (Hillen et al., 2015). We indirectly addressed this by performing our
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2PM experiments with either anti-IL-7 or anti-IL-7R, and observed reduced motility with
anti-IL-7 and no significant effect with IL-7R, suggesting that the motility inhibition is
due to blocking IL-7/IL-7R signaling in T cells and not TSLPR signaling on other cells.
4.5. Regionalized normalized mutual information for analyzing fluorescence microscopy
colocalization
Normalized mutual information (NMI) is derived from Shannon information
theory and it quantifies how much information is shared between two fluorescent
channels that represent different cell types. Determining the NMI between two cell types
is achieved by minimizing the uncertainty of Cell Type A’s location based on the known
locations of Cell Type B. It is similar to Pearson’s correlation coefficient (PCC) in that it
does not require pre-processing of images (e.g. thresholding), and that it considers the
fluorescence intensity in addition to the co-occurrence of fluorescence from two channels
(Mander’s overlap coefficient differs in this regard) (Dunn et al., 2011). NMI is distinct
from PCC and other colocalization measures in that it was adapted to assess associations
between cells, and not protein-protein association within the same cell type. Additionally,
it is more appropriate for quantifying non-linear associations than PCC and it is less
responsive to differences in cell number between the compared populations. We find
NMI to be a complementary approach to PCC and its limitations are discussed below.
4.5.1. Limitations of NMI analysis of 2PM images
NMI and PCC measure the co-occurrence and co-variance of fluorescence overlap
at the level of a pixel. In our system, each cell type we compare only has one fluorescent
marker. Because two cells cannot fill the same space in a pixel, any fluorescence
colocalization we identify is due to insufficient pixel resolution to discriminate between
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the boundary of two cells. To address this, we adapted NMI to be calculated over regions
within images (RNMI), in which NMI is calculated using the average fluorescence
intensity of all the pixels in the region. This allows for assessment of intercellular
interactions by expanding the area over which the cell:cell association is calculated.
However, a limitation of this approach is that the choice of region sizes is arbitrary or, at
the least, subjective. Region sizes were selected based on the sizes of cells that were
being compared, and these cell sizes were determined by manually measuring cells in our
images. Determining the most relevant region size for interpreting the data is challenging.
For example, when performing RNMI on T:DC images, we are unable to conclude
whether the 6 µm x 6 µm region size is more relevant than the 18 µm x 18 µm region
size. Naïve T cells are closer to 6 µm than 15 µm, but DCs are at least 15 µm in length.
For this reason, we calculate RNMI across a range of region sizes. Another limitation of
our technique is the resolution of the microscope images. Even with regionalization, the
pixel resolution may affect how finely we can detect intercellular associations. This is
especially true in the z-direction in the analyzed images, as RNMI is calculated on 3D
regions and the z-step is larger than the size of our XY pixels.
In Chapter 3 we develop a novel method to assess cell:cell association using
mutual information (Tasnim et al., 2018b). By RNMI, our results suggested that T cells
associate more with FRCs than DCs. One confirmatory experiment would be to use NMI
to analyze the association between DCs and the FRC network. We hypothesize that
FRC:DC association may be low, as T:DC association is low while T:FRC association is
high. One possible outcome is high RNMI of DCs and FRCs. It can be interpreted that
the high FRC:DC association does not increase the likelihood of T cells associating with

105

DCs even though T:FRC interaction is high, because T:DC association is low. While this
finding would be surprising, it could support the model that T cells crawl along FRCs as
a network, potentially enhancing T cell access to key survival factors produced by FRCs
such as IL-7. On the other hand, if FRC:DC interaction is low, then that would suggest
that DCs are not situated along FRCs, and that T cells interact with DCs potentially
independently of T:FRC interactions. T cells may be colocalized with FRCs but not with
DCs, and DCs are not colocalized with FRCs, so the FRC:DC association is not likely to
influence the T:DC interaction. Even without FRC:DC colocalization data, we provide
evidence rejecting the hypothesis that DCs are strategically positioned for optimal
interactions with T cells.
The intercellular colocalization analyses and the discovery of IL-7 as a novel
driver of naïve T cell motility support a model in which T cell interactions with DCs are
chance encounters, and not orchestrated by the environment or by intercellular signaling
to be optimized or directional. Studies by our lab and others fail to show that motilityinducing cytokines and chemokines chemotactically attract T cells to DCs in the
paracortex of the lymph node. Blockade of IL-7/IL-7R decreased unique T cell contacts
with targets in a computational model (Figure 2.5B), but this was likely through
modulation of T cell speed only. Analysis of turning angles of T cell tracks near DCs
before and after IL-7/IL-7R blockade showed that T cells do not move directionally to
DCs. Huang et al. reported CCR7-/- T cells have a slight change in turning angle
compared to WT T cells, whereas Okada et al. reported there was no significant change
(Huang et al., 2007; Okada and Cyster, 2007). These experiments did not assess turning
angles relative to DC positions, so it is not possible to conclude whether CCR7 affects

106

T:DC contacts through a chemotactic mechanism. The effect of LPA on DC-induced
chemotaxis in vivo has not been explored in detail. It is possible that CCR7 ligands, LPA,
and/or IL-7 are indeed chemotactic in the LN, but do not function to recruit T cells to
DCs, but instead may lead T cells to FRCs. It would be valuable to perform turning angle
analysis of T cells relative to FRC distance with different motility-inducing factors
blocked including in the absence of CCR7 and LPAR. The consequence of FRCs
attracting T cells may not enhance T:DC interactions directly, but possibly to facilitate
high speed T cell motion through contact guidance, for access to growth/survival factors,
or to suppress T cell activation through FRC-mediated contact inhibition in the absence
of activated DCs (Siegert and Luther, 2012; Siegert et al., 2011). To date, much has been
discovered about molecular mediators of T cell motility and the structure of the lymph
node paracortex, yet there is not direct experimental evidence that naïve T cells in vivo
are receiving cues that trigger directional search strategies toward targets in the
paracortex. While directional motion may be induced toward a chemical source in vitro,
it is possible the paracortex is more well-mixed, with no distinguishable gradients of
molecules or meaningful positioning of targets.
4.5.2. Role of FRC in promoting T:DC interactions in the LN
The FRC network is a lymphatic conduit system which is sheathed by fibroblastic
stromal cells that demarcate the T cell zone of the lymph node. FRCs are important for
the structure of the LN in that they provide tensile mechanical scaffold, and relaxation of
the network tension allows for an increase in LN cellularity (e.g. during infection) of
immune cells as well as expansion of the FRC population. Maintenance of the T cell
population and FRCs are mutually dependent; FRCs support naïve T cells through IL-7
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production, and CD4+ T cells are a significant source of lymphotoxin β, which is
required for FRC network formation (Fletcher et al., 2015; Zeng et al., 2012b, 2012a).
DCs receive signals from the FRC network, too, for antigen acquiration and chemokinemediated migration (Acton et al., 2012b; Brown and Turley, 2015; Sixt et al., 2005a).
Because the FRC network provides both structure and secreted signals to DCs and T
cells, abrogation of the FRC network can limit T cell responses to antigen (Denton et al.,
2014; Suenaga et al., 2015). Recent literature argues that an intact and functional FRC
network can also attenuate T cell responses or otherwise regulate T cell activation by
multiple mechanisms, such as production of nitric oxide, regulating FRC network tension
and spacing of T cells and the network, mediating DC migration, or providing haptic
guidance to migrating T cells (Acton et al., 2012b; Astarita et al., 2015; Bajénoff et al.,
2006; Khan et al., 2011; Siegert et al., 2011).
T:FRC interactions have recently been discovered to suppress T cell activation
through nitric oxide release (Khan et al., 2011; Lukacs-Kornek et al., 2011; Siegert et al.,
2011). Astarita et al. showed that under naïve conditions, FRCs are in a tense or
contractile state which is controlled by podoplanin signaling. When podoplanin is
blocked, which occurs when migratory CLEC-2-expressing DCs interact with FRCs, the
network relaxes. This relaxation actually increases the distance between T cells and
FRCs, possibly allowing for greater T cell expansion (Astarita et al., 2015). Thereby,
FRCs restrict T cell activation in the naïve LN through contact-mediated inhibition until
an inflammatory stimulus (influx of activated DCs) relieves the contractile force of the
network. Our results showing that T cells may be more associated with FRCs than DCs
may be due to the tension of the network in the absence of antigen. Due to the FRC
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network being localized specifically in the LN paracortex and the abundance of FRCderived chemokines and IL-7, current FRC literature hypothesizes that T cells migrate
along the FRC network as if they are paved roads for trafficking, and that DCs are
positioned on top of this network both to acquire antigen from the FRC-sheathed
lymphatics and also to increase the probability of T:DC interactions, enhancing the
efficiency of T cell activation. Additionally, literature has suggested that DCs are
enriched near HEV portals, and that T cells move directly from the HEV to the FRC
network to interact with ideally localized DCs to promote rapid T cell responses
(Bajénoff et al., 2003; Brown and Turley, 2015; Fletcher et al., 2015; Mempel et al.,
2004). A framework in which T cells are in contact with FRCs and are suppressed until
activated DCs migrate to the LN and de-stress the FRC network to poise T cells for
activation is more plausible than a framework in which T cells enter the paracortex and
preferentially associate with FRCs which guide them to DCs that are preferentially
associated with the FRC network near HEVs, indicating a type of higher organization for
which we do not yet have molecular evidence. Performing NMI on images from an
inflamed LN or a podoplanin-blocked FRC network could inform the role for FRCs in
modulating T:DC associations.
4.6. Future directions: Linking IL-7 mediated naïve T cell motility to metabolism regulated
by IL-7
IL-7 is an established regulator of T cell metabolism (Cui et al., 2015; Jacobs et
al., 2010b; Wofford et al., 2008). We demonstrate that IL-7 can also regulate naïve T cell
motility. Cell motility is regarded as an energy-expensive process, and it is probable that
the mechanism driving IL-7-mediated motility is through metabolic regulation. Our
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future directions include determining whether these effects of IL-7 are linked. Possible
avenues of experimentation are discussed here.
IL-7 maintains glycolysis in T cells via GLUT1 expression, whereas neglected T
cells lose GLUT1 expression at the membrane (Rathmell et al., 2001; Wofford et al., 2008).
Interestingly, GLUT1 is not required for survival of naïve T cells through IL-7R signaling
(Macintyre et al., 2014). IL-7R-deficient T cells have less glucose metabolism (Jacobs et
al., 2010a). Connections between glucose metabolism and naïve T cell motility have not
been explored, though glycolytic flux is critical for motility of T regulatory cells and the
glucose metabolite lactate inhibits migration of effector T cells (Haas et al., 2015; Kishore
et al., 2017). Glucose metabolism is differentially regulated among naïve T cells, effector
T cells, memory T cells, and regulatory T cells, so while it is hypothesized that glucose
uptake via IL-7-driven GLUT1 expression will promote naïve T cell motility, the
mechanism may indeed be distinct from glucose-regulated motility in T effector cells and
regulatory T cells because their metabolic needs are different and their default glucose
conversion pathways are different. A plan to test the role for GLUT1 in IL-7-induced
motility is to first assess the phenotype of mitochondria in naïve T cells in the LN with and
without GLUT1 blockade. The number, localization, or whether the mitochondria are fused
or distinct can be assessed for the effect of GLUT1 on mitochondrial dynamics. In vitro
naïve T cells can be rested (neglected) or maintained in IL-7-containing media with or
without GLUT1 inhibitor. Mitochondrial phenotype, glucose uptake and respiration, and
cytoskeleton remodeling can be assessed. GLUT1 inhibition in the explant LN model and
quantification of naïve T cell speeds by 2PM can also be performed using GLUT1 inhibitor
Bay-876 (Siebeneicher et al., 2016). If motility inhibition is observed with GLUT1
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inhibition, but no further inhibition is seen with combined anti-IL-7 and GLUT1 inhibition
compared to anti-IL-7 blockade alone, then the result may indicate a role for GLUT1 in
mediating IL-7-mediated motility. Conditional knockout mice with GLUT1-deficient CD4
T cells have also been generated (Macintyre et al., 2014; Young et al., 2011), and this is
another option for exploring the effect of GLUT1 in IL-7-mediated naïve T cell motility.
Chemokine receptor signaling or IL-7 may promote uptake of glucose to meet metabolic
demands of motility, as has been shown to be true in effector cells with CCR5 regulating
glucose uptake (Chan et al., 2012). Alternatively, glucose uptake and glycolysis may also
regulate chemokine receptor expression at the membrane.
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Appendices
Appendix A: Chapter 2 supplemental figures

Figure S.2.1. In vitro migration of T cells relative to input number of T cells. Data
pooled from 5 experiments. Each experiment had 2 technical replicates (2 experiments) or
3 technical replicates (3 experiments). Unpaired student’s two-tailed T Test p value relative
to media (no chemokine) = 0.0001 for CCL21, p = 0.7205 for IL-7 treatment. Combined
CCL21 and IL-7 treatment relative to CCL21 treatment alone, p = 0.5221.
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Figure S.2.2. Erk phosphorylation of DND-41 cells. Serum-starved DND-41 cells were
unstimulated or treated with CCL21 (1 µg mL-1), IL-7 (1 µg mL-1), or combined CCL21
(1 µg mL-1) and IL-7 (1 µg mL-1) for 3 minutes before harvesting. Anti-p-Erk1/2 was
used to assay for Erk phosphorylation by flow cytometry. (A) Representative gating for
percent of p-Erk1/2+ cells in population gated on single cells (FSC-A x FSC-H). (B) Fold
change in percent of p-Erk1/2+ DND-41 cells relative to unstimulated DND-41 cells.
Unstimulated median = 1.0132. IL-7 median = 1.2643. CCL21 median = 4.0963. CCL21
+ IL-7 median = 3.4433. Mann Whitney test p values indicated on graph. Data are from 5
experiments with 3 replicates each (n = 15 in each group).
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Appendix B: Chapter 3 supplemental figures

Figure S.3.1. Illustration of the highest and lowest NMI that can be generated from
the experimental data. The NMI of an image with itself is the maximum value of 1, shown
for an example image of red cells and an example image of green cells. To obtain a
minimum value, we calculate NMI between two images, one red and one green from two
different fields so that the images are unrelated. We calculated NMI from 5,036 pairs of
frames (Unmatched Red:Green). For this unmatched scenario, the NMI is very close to 0
(median is 0.008).
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Figure S.3.2. NMI is more robust than PCC to cell count. Simulated images were
generated in which numbers of cells in the green and red channels are varied by number
and positions varied as indicated. Apparent association of cell types based purely on the
increased chance of two cells being near one another as the number of cells goes up is a
concern. The normalization factor in NMI is intended to compensate for this artifact.
Insensitivity to variation in cell number while preserving sensitivity to the underlying
association between cell types distinguishes NMI from PCC. The number of cells in the
green channel is kept constant at 500 while the number of cells in the red channel is varied.
NMI results are shown in the left column and PCC in the right column. The spatial
association between cell types in the model decreases from σ = 0 in the top row to uniform
random placement in the bottom row.
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